[
    {
        "type": "text",
        "text": "Lindenane-Based Sesquiterpenoid Hetero-Oligomers with Diverse Skeletons and Extracellular Regulated Protein Kinases Inhibitory Activity from Sarcandra glabra ",
        "text_level": 1,
        "bbox": [
            82,
            135,
            896,
            205
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Danyang Zhang, Zhiqi Xiao, An Huang, Pengfei Tang, Houli Jiang, Mengmeng Yu, Ze Zheng, Lingyi Kong,\\* and Jun Luo\\* ",
        "bbox": [
            84,
            210,
            848,
            246
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Cite This: J. Nat. Prod.2025,88,2181-2192 ",
        "bbox": [
            123,
            261,
            372,
            275
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Read Online ",
        "text_level": 1,
        "bbox": [
            556,
            262,
            635,
            275
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "ACCESS | ",
        "text_level": 1,
        "bbox": [
            84,
            301,
            172,
            320
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "ll Metrics & More 回Article Recommendations s1 Supporting Information ",
        "bbox": [
            232,
            306,
            355,
            320
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            451,
            306,
            632,
            318
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            711,
            306,
            873,
            318
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "ABSTRACT: Sarcglabtenes $_ { \\mathrm { A - G } }$ (1-7)， seven lindenane-based sesquiterpenoid hetero-oligomers with six unprecedented skeletons,along with five new biosynthetic analogues sarcglabtenes $_ \\mathrm { H - L }$ (8-12)，were isolated from Sarcandra glabra. Their structures including absolute configurations were comprehensively elucidated using HR-MS,NMR, ECD,and single crystal X-ray diffraction. Structurally, sarcglabtenes $_ { \\mathrm { A - G } }$ are lindenane heterooligomers including a geranyl homogentisic acid $\\mathbf { ( 1 / 2 ) }$ ， geranylgeranyl $p$ -toluquinone (3/4)， germarane (5)，campholenal $( 6 / 7 )$ ",
        "bbox": [
            84,
            335,
            505,
            460
        ],
        "page_idx": 0
    },
    {
        "type": "image",
        "img_path": "images/dad6747aba3dafb894c65884d564a3a4358114740a8f776b2c105d723efb152e.jpg",
        "image_caption": [],
        "image_footnote": [],
        "bbox": [
            517,
            335,
            915,
            440
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "derivatives,for which plasiblebiosynthesis pathways arealsoproposed.Inbioasays,1-4exhbitedcytotoxicactivityagainst five cancercellinndinatilar4aedetraelareglatedproteininae (rkbofteAsigangpathy involved in apoptosis. ",
        "bbox": [
            82,
            461,
            919,
            501
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "N Their unique scaffolds and biological activities provide valuable molecular templates for the discovery of innovative drugs.1,2 Lindenane sesquiterpenoids (LSs),especially their oligomers, are the primary and characteristic metabolites of the Chloranthaceaeous plant,and exhibit a wide range of bioactivities，such as anti-inflammatory，antitumor，and antimalarial effects.³ The highly conjugated double bonds in LSs enable the formation of homo-oligomers via $[ 4 ~ + ~ 2 ]$ cycloaddition, $[ 2 ~ + ~ 2 ]$ cycloaddition，and $[ 6 ~ + ~ 6 ]$ cycloaddition. Among the LS oligomers,the first to be discovered and the most common is the classical $[ 4 + 2 ]$ dimer formed by the intermolecular Diels-Alder reaction between $\\Delta ^ { 1 5 ( 4 ) , 5 ( \\acute { 6 } ) }$ and $\\Delta ^ { 8 \\prime , ( 9 \\prime ) } . ^ { 3 - 5 }$ Furthermore,the lindenane unit of $\\Delta ^ { 1 5 ( 4 ) , 5 ( 6 ) }$ presents the capacity to engage with other double bonds found within the non-LS unit, thereby facilitating the formation of hetero-oligomers characterized by unparalleled structural diversity.6,7 Recently,an increasing number of such heterooligomers have been identified,including the LS and monoterpene dimers sarglaoxolanes $_ { \\mathrm { A - C } }$ with anti-inflammatory activity，as well as the LS and $p$ -benzoquinonemeroterpenoid trimer holotrichone B, known for its antileukemic properties.8,9 Given their exceptional structural variability，heteropolymerized lindenane oligomers，asa newly recognized class，exhibit significant potential for innovative biological activities and applications，deserving further investigation and exploration. ",
        "bbox": [
            82,
            528,
            482,
            935
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Encouraged by our previous research on LS from S. glabra,4,8 a well-known and commonly used traditional Chinese medicine，we conducted a reinvestigation of S. glabra to identify novel structures10 Asa result,sarcglabtenesA-G $\\left( 1 - 7 \\right)$ ，seven lindenane-based sesquiterpenoid heterooligomers with six unprecedented skeletons and five new biosynthetic analogues (8-12),were discovered and comprehensively elucidated using HR-MS,NMR, ECD,and single crystal X-ray diffraction (Figure 1). Their cytotoxic activities against on five cancer cell lines and the mechanism of action of the unique heterotrimer 4as an extracellular regulated protein kinase (Erk) inhibitor were also elucidated.Herein,we report the isolation， structural elucidation，plausible biogenetic pathways,and Erk-targeted cytotoxicity of $\\mathbf { 1 } - \\mathbf { 1 } \\mathbf { 2 }$ ： ",
        "bbox": [
            517,
            531,
            915,
            723
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "RESULTS AND DISCUSSION ",
        "text_level": 1,
        "bbox": [
            520,
            740,
            752,
            755
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Sarcglabtene A(1） was obtained as a yellowish gum,and its molecular formula $\\mathrm { C _ { 5 1 } H _ { 6 0 } N a O _ { 1 2 } }$ was established by the sodium adduct positive HRESIMS at $m / z ~ 8 8 7 . 3 9 7 6$ $[ \\mathbf { M _ { \\mathrm { ~ + ~ } } }$ $\\mathrm { N a } ] ^ { + }$ (calcd 887.3977), indicating the presence of 22 indices of hydrogen deficiency. The $^ 1 \\mathrm { H }$ NMR（Table S1）and HSQC spectra showed two pairs of specific upfield characteristic cyclopropane methylene protons at $\\delta _ { \\mathrm { H } }$ 0.83 $( \\mathrm { H } \\cdot 2 \\alpha ,$ overlapped)/0.18 $\\left( \\operatorname { H } \\mathbf { - } 2 \\beta , \\mathrm { ~ m ~ } \\right)$ and 0.77 $\\left( \\mathrm { H } { - } 2 ^ { \\prime } \\alpha , \\ m \\right) / 0 { . } 4 4$ $( \\mathrm { H } \\cdot 2 ^ { \\prime } \\beta ,$ m),characteristic geranyl protons at $\\delta _ { \\mathrm { H } } ~ 5 . 1 2 $ $\\left( \\mathrm { H } { - } 2 ^ { \\prime \\prime \\prime } \\right)$ ,br t 7.2) and 5.08 $\\mathrm { ( H } \\mathrm { - } 6 ^ { \\prime \\prime \\prime }$ ,br t 7.2),and ten methyl protons at $\\delta _ { \\mathrm { H } } ~ 0 . 8 6$ (s),1.17 (s),1.30 (s),1.60 (s),1.62 (s),1.68 (s),2.14 (s),3.67 (s),3.68 (s) and 3.84 (s). The combination of $\\delta _ { \\mathrm { H } }$ 4.41 $[ \\mathrm { H } \\cdot \\boldsymbol { 5 } ^ { \\prime \\prime }$ d (4.6)] with $\\delta _ { \\mathrm { C } } 2 0 0 . 6 \\left( \\mathrm { C } - 1 ^ { \\prime \\prime } \\right)$ ，and $\\delta _ { \\mathrm { C } }$ 199.3 $\\left( \\mathbf { C } \\mathbf { - } 4 ^ { \\prime \\prime } \\right)$ revealed the existence of a quinone moiety. Thorough analysis of the NMR resonance spectra and MS data indicated that 1 was a novel hetero-LS oligomer consisting of two LS units and one other unit contained a quinone and a geranyl group. ",
        "bbox": [
            517,
            761,
            915,
            830
        ],
        "page_idx": 0
    },
    {
        "type": "image",
        "img_path": "images/c7fb5e79da6535d841d8fbc694a691e9862d97f2e4f0d93f48c14f8e0eed0a11.jpg",
        "image_caption": [
            "Figure 1. Chemical structures of sarcglabtenes $_ { \\mathrm { A - L } }$ (1-12). "
        ],
        "image_footnote": [],
        "bbox": [
            85,
            72,
            887,
            641
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            84,
            671,
            481,
            842
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "The 1D NMR data of 1 were similar to those of holotrichone B with a $\\mathrm { C _ { 1 } { - } C _ { 6 } { - } C _ { 1 0 } }$ unit $C ^ { 9 }$ ;however,1 featured a $C _ { 2 } { \\mathrm { - } } C _ { 6 } { \\mathrm { - } } C _ { 1 0 }$ unit C,which was an essential difference in the skeleton.Unit C of 1 featured the substitution of a methyl acetate fragment for the methyl group at $\\mathrm { C } { - } 6 ^ { \\prime \\prime }$ in holotrichone B,and the replacement of the $\\bar { \\Delta } ^ { 2 \\prime \\prime , \\bar { 3 } \\prime \\prime }$ double bond with the $\\Delta ^ { 5 \\prime \\prime , 6 \\prime \\prime }$ double bond present on holotrichone B, both of which were confirmed by key HMBC correlations (Figure 2A） from $\\mathrm { H } { - } 7 ^ { \\prime \\prime }$ to $\\mathrm { { C } } { \\cdot } 1 ^ { \\prime \\prime }$ $C { - } 5 ^ { \\prime \\prime }$ $( \\delta _ { \\mathrm { C } } 5 1 . 3 )$ ， $\\mathrm { C } { - } 6 ^ { \\prime \\prime }$ $( \\delta _ { \\mathrm { C } } 5 2 . 1 )$ and $\\mathrm { C } { - } 8 ^ { \\prime \\prime }$ ,from $\\mathrm { O C H } _ { 3 } – 8 ^ { \\prime \\prime }$ to $\\mathrm { C } { - } 8 ^ { \\prime \\prime }$ and from $\\mathrm { H } { - } 3 ^ { \\prime \\prime }$ $\\left( \\delta _ { \\mathrm { H } } ~ 6 . 3 6 , ~ s \\right)$ to $C { - } 2 { ^ { \\prime \\prime } }$ $\\mathit { \\Delta } _ { \\delta _ { \\mathrm { C } } }$ 148.3).Furthermore, the $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlation between the proton signal of H-6 of unit A and $\\mathrm { H } { - } 5 ^ { \\prime \\prime }$ of unit C and the HMBC correlations (red arrows in Figure 2A） from proton signals of $\\mathrm { H } { - } 5 ^ { \\prime \\prime }$ of unit C to the carbon signals of unit A at C-5, C-6, C-7,and C-15,and from proton signals $\\mathrm { H } _ { 2 } { \\cdot } 1 5$ of unit A to the carbon signals of unit $\\textrm { C }$ at $\\mathrm { { C } } { \\cdot } 1 ^ { \\prime \\prime }$ ， $C { - } 5 ^ { \\prime \\prime }$ ， $\\mathrm { C } { - } 6 ^ { \\prime \\prime }$ ，and $\\mathrm { C } { \\cdot } 7 ^ { \\prime \\prime }$ indicated that units Aand C of 1 were bridged by the C-15-C$6 ^ { \\prime \\prime }$ and $C { - } 6 { - } \\mathrm { C - } 5 ^ { \\prime \\prime }$ bonds formed through $[ 4 ~ + ~ 2 ]$ cycloaddition.Thus,the planar structure of 1 was thus delineated as the first example of a lindenane-geranyl homogentisic acid oligomer. ",
        "bbox": [
            82,
            843,
            481,
            942
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            518,
            671,
            915,
            871
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "The relative configurations of units A and B were similar to that of holotrichone $\\mathbf { B } , ^ { 9 }$ which was determined by ROESY correlations (Figure 2A） of $\\mathrm { H } { - } 6 / \\mathrm { H } { - } 5 ^ { \\prime \\prime } / \\mathrm { H } _ { 3 } { - } 1 3 / \\mathrm { H } { - } 1 5 ^ { \\prime } \\alpha / \\mathrm { H } { - } 6 ^ { \\prime } $ and $\\mathrm { H } _ { 3 } – 1 3 / \\mathrm { H } \\mathrm { - } 1 5 \\beta / \\mathrm { H } \\mathrm { - } 2 ^ { \\prime } \\beta / \\mathrm { H } _ { 3 } – 1 4 ^ { \\prime }$ ，aswell as by biosynthetic considerations. $\\mathrm { H } _ { 3 } – 1 3$ exhibited a ROESY correlation with H",
        "bbox": [
            518,
            872,
            915,
            942
        ],
        "page_idx": 1
    },
    {
        "type": "image",
        "img_path": "images/58e12aae863163c70cdd926ebc5ab2490158709c7b80b174193a30b7b1faa7ab.jpg",
        "image_caption": [
            "Figure 2. Structural elucidation of 1. (A) Key 2D correlations of 1, (B) experimental ECDand UV spectra of 1-4. "
        ],
        "image_footnote": [],
        "bbox": [
            153,
            76,
            827,
            746
        ],
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "$5 ^ { \\prime \\prime }$ on the $\\alpha$ -configured C-5,which confirmed that $\\mathrm { H } _ { 3 } – 1 3$ was in the $\\alpha$ -configuration (equatorial bond).The $\\Delta ^ { 2 \\prime \\prime \\prime , \\left( 3 \\prime \\prime \\prime \\right) }$ and $\\Delta ^ { 6 \\prime \\prime \\prime , ( 7 \\prime \\prime \\prime ) }$ double bonds were assigned an $E$ geometry by the ROESY correlations of $\\mathrm { H } { - } 1 ^ { \\prime \\prime \\prime } / \\mathrm { H } { - } 1 \\bar { 0 } ^ { \\prime \\prime \\prime }$ ， $\\mathrm { H } { - } 2 ^ { \\prime \\prime \\prime } / \\mathrm { \\bar { H } } { - } 4 ^ { \\prime \\prime \\prime }$ $\\mathrm { H } { - } 5 ^ { \\prime \\prime \\prime } / \\mathrm { H } { - }$ $9 ^ { \\prime \\prime \\prime }$ ， $\\mathrm { H } { - } 6 ^ { \\prime \\prime \\prime } / \\mathrm { H } { - } 8 ^ { \\prime \\prime \\prime }$ . The relative configuration at the new polymerization site in units A and C was established through key ROESY correlations of $\\mathrm { H } { - } 5 ^ { \\prime \\prime } / \\mathrm { H } { - } 6 / \\mathrm { H } { - } 7 ^ { \\prime \\prime }$ and ${ \\mathrm { H } } { - } 6 / { \\mathrm { H } } _ { 3 } { - } \\bar { 1 4 }$ indicating $\\beta$ -orientation of H-6, $C { - } 7 ^ { \\prime \\prime }$ ，and $\\mathrm { H } { - } 5 ^ { \\prime \\prime }$ .The subsequently recorded ECD spectrum of 1 (Figure 2B) exhibited a split Cotton effect:a negative Cotton effect at $3 3 3 ~ \\mathrm { n m }$ $\\left( \\Delta \\varepsilon - 1 . 5 7 \\right)$ and a positive Cotton effect at $2 7 6 ~ \\mathrm { n m }$ $\\left( \\Delta \\varepsilon + 2 . 0 0 \\right)$ ,indicating a negative chirality that corresponded to a counterclockwise transition-dipole arrangement between the two chromophores.12 Furthermore, the experimental ECD trend of 1 was highly consistent with the experimental ECD trend of holotrichone $\\mathbf { B } , ^ { 9 }$ whereas the absolute configurations of known LSs with overlapping biogenetic pathways further confirmed the above results.3,9,i2bThus,the absolute configuration of 1 was established as 1R,3S,6R,9R，10S, $1 ^ { \\prime } R , 3 ^ { \\prime } S , 4 ^ { \\prime } R , 9 ^ { \\prime } R , 1 0 ^ { \\prime } S , 5 ^ { \\prime \\prime } S , 6 ^ { \\prime \\prime } S .$ ",
        "bbox": [
            84,
            772,
            479,
            942
        ],
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            518,
            773,
            914,
            886
        ],
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Sarcglabtene B (2）exhibited the same chemical formula $( \\mathrm { C } _ { 5 1 } \\mathrm { H } _ { 6 0 } \\mathrm { N a O } _ { 1 2 } )$ and similar 1D NMR data (Tables S1 and S2) as those of 1, indicating the same biosynthetic precursors and polymerization form, the LS dimer (units A and B）and a geranyl homogentisic acid derivative (unit C). The difference layin the fact that 2 was formed through the connection of two new bonds, $\\mathrm { C } { \\cdot } 1 5 { - } \\mathrm { C } { \\cdot } 2 ^ { \\prime \\prime }$ and $\\mathrm { C } { \\cdot } 6 { \\mathrm { - } } \\mathrm { C } { \\cdot } 3 ^ { \\prime \\prime }$ ，viaa $[ 4 ~ + ~ 2 ]$ cycloaddition pathway at new sites between units A and C, leading to the formation of a unique skeleton. This was further supported by the HMBC correlations from $_ { \\mathrm { H } _ { 2 } - 1 5 }$ to $\\mathrm { { C } } { - } 1 ^ { \\prime \\prime \\prime }$ ,C$1 ^ { \\prime \\prime }$ $C { - } 2 { ^ { \\prime \\prime } }$ and $\\mathbf { C } { - } 3 ^ { \\prime \\prime }$ ，from $\\mathrm { H } { - } 3 ^ { \\prime \\prime }$ to C-5, C-6, C-7 and C-15 and the $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlation of $\\mathrm { H } { - } 6 / \\mathrm { H } { - } 3 ^ { \\prime \\prime }$ . The similar ROESY data (Figure S1) and ECD spectrum (Figure 2B) of 2 and 1 suggested that these two compounds possessed identical relative and absolute configurations. Thus, the structure of 2 with new $[ 4 + 2 ]$ polymerization framework was determined as shown in Figure 1. ",
        "bbox": [
            517,
            886,
            914,
            942
        ],
        "page_idx": 2
    },
    {
        "type": "image",
        "img_path": "images/0359ec923b90a4725cf71cb8d580d48b3d9288f9ed76c2f6ce78b2e1d8bf8ace.jpg",
        "image_caption": [
            "Scheme 1.Putative Biosynthetic Pathways for 1-7 "
        ],
        "image_footnote": [],
        "bbox": [
            88,
            96,
            911,
            463
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            84,
            475,
            479,
            658
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "Sarcglabtene C (3)and D (4) also showed same molecular formula $\\mathrm { C _ { 5 9 } H _ { 7 4 } O _ { 1 0 } }$ based on ion peaks at $m / z 9 6 5 . 5 1 7 6 [ \\mathrm { M }$ $[ \\mathbf { M } + \\mathbf { \\Gamma }$ $\\mathrm { N a } ] ^ { + }$ and 965.5177 $[ \\mathbf { M } + \\mathbf { N a } ] ^ { + }$ in HRESI $( + ) \\mathbf { M } \\mathbf { S }$ spectra and similar 1D NMR data (Table S3 and Table S4)，which indicated that they were also isomers as 1 and 2.By comparing their NMR data,3(Table S3) was structurally similar to 1 but differed in that 3 featured a new $C _ { 1 } { - } C _ { 6 } { - } C _ { 2 0 }$ unit C instead of the $C _ { 2 } { \\mathrm { - } } C _ { 6 } { \\mathrm { - } } C _ { 1 0 }$ unit $\\textrm { C }$ in 1.Unit C of 3 involved the substitution of a methyl group for the methyl acetate fragment at $\\mathrm { C } { - } 6 ^ { \\prime \\prime }$ in 1,and the replacement of the geranyl group at $C { - } 2 { ^ { \\prime \\prime } }$ with a geranylgeranyl group in 1，both of which were confirmed by key HMBC correlations (Figure S2） from $\\mathrm { H } _ { 2 } .$ 15 to $\\mathrm { { C } } { \\cdot } 1 { \\mathrm { { } } ^ { \\prime \\prime } }$ ， $C { - } 5 ^ { \\prime \\prime }$ ， $\\mathrm { C } { - } 6 ^ { \\prime \\prime }$ and $\\mathrm { C } { \\cdot } 7 ^ { \\prime \\prime }$ ，from $\\mathrm { H } – 8 ^ { \\prime \\prime \\prime }$ to $\\mathrm { { C } } { - } 1 ^ { \\prime \\prime \\prime }$ ，from $\\mathrm { H } _ { 3 } – 1 0 ^ { \\prime \\prime \\prime }$ to $\\mathrm { C } { - } 2 ^ { \\prime \\prime \\prime }$ ， $\\mathrm { C } { - } 3 ^ { { \\prime } { \\prime } { \\prime } { \\prime } }$ ,and $\\mathrm { { C - 4 } ^ { \\prime \\prime \\prime } }$ ，from $\\mathrm { H } _ { 2 } { - } 4 ^ { \\prime \\prime \\prime \\prime }$ to $\\mathrm { C } { - } 5 ^ { \\prime \\prime \\prime }$ ， and from $\\mathrm { H } _ { 3 } { - } 9 ^ { \\prime \\prime \\prime }$ to $\\mathrm { C } { - } 6 ^ { \\prime \\prime \\prime }$ ， $\\mathrm { { C - 7 ^ { \\prime \\prime } } ^ { \\prime \\prime } }$ ,and $\\mathrm { C } { - } 8 ^ { \\prime \\prime \\prime }$ ,and the $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlation of $\\mathrm { H } { - } 2 ^ { \\prime \\prime \\prime } / \\mathrm { H } _ { 2 ^ { - } } 1 ^ { \\prime \\prime \\prime }$ ，and $\\mathrm { H } { - } 6 ^ { \\prime \\prime \\prime } / \\mathrm { H } _ { 2 } { - } 5 ^ { \\prime \\prime \\prime }$ ： Similar to 1，units A and C of 3 were unprecedentedly bridged by the $\\mathrm { C } { - } 1 5 { - } \\mathrm { C } { - } 6 ^ { \\prime \\prime }$ and $C { - } 6 { - } \\mathrm { C - } 5 ^ { \\prime \\prime }$ bonds through $[ 4 +$ 2] cycloaddition,as evidenced by HMBC correlations from $\\mathrm { H } _ { 2 } { \\cdot } 1 5$ to $\\mathrm { C } { - } 1 ^ { \\prime \\prime } , \\mathrm { C } { - } 5 ^ { \\prime \\prime } , \\mathrm { C } { - } 6 ^ { \\prime \\prime } .$ and $\\mathrm { { C - 7 ^ { \\prime \\prime } } }$ ，and from $\\mathrm { H } { - } 5 ^ { \\prime \\prime }$ to C-5, ",
        "bbox": [
            84,
            658,
            481,
            942
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "C-6, C-7,and C-15,as well as $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlation of H$6 / \\mathrm { H } { - } 5 ^ { \\prime \\prime }$ .The $^ 1 \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR spectra of 4 (Table S4) were very close to those of 3 (Table S3), with only difference on the chemical shifts for $\\mathrm { C } { - } 2 ^ { \\prime \\prime }$ $\\mathrm { C } { - } 3 ^ { \\prime \\prime }$ $C { - } 5 ^ { \\prime \\prime }$ ， $\\mathrm { C } { \\cdot } 6 ^ { \\prime \\prime }$ $\\mathrm { C } { \\cdot } 7 ^ { \\prime \\prime }$ ,and $\\mathbf { C } { - } \\mathbf { l } ^ { \\prime \\prime \\prime }$ of unit C. From a biosynthetic viewpoint，3 might be biosynthesized from LS dimer (units A and B)，which was supposed to be the diene, coupled with a dienophile group of the geranylgeranyl toluquinone (unit C） through a $[ 4 + 2 ]$ cycloaddition (Scheme 1).Therefore, it was reasonable to infer that 4 was also formed from the same biosynthetic precursors of LS dimer (units A and B） and geranylgeranyl toluquinone (unit C）in another $[ 4 ~ + ~ 2 ]$ cycloaddition direction, theoretically, based on the 1D NMR data between 3 and 4. This was secured by the key HMBC correlation of 4 (Figure S3) from $\\mathrm { H } _ { 2 } { \\cdot } 1 5$ to $\\mathrm { { C } } { \\cdot } 1 { \\mathrm { { } } ^ { \\prime \\prime } }$ $C { - } 2 { ^ { \\prime \\prime } }$ $\\mathrm { C } { - } 3 ^ { \\prime \\prime }$ ,and $\\mathrm { { C } } { - } 1 ^ { \\prime \\prime \\prime }$ ,and from ${ \\bar { \\mathrm { H } } } { - } 3 ^ { \\prime \\prime }$ to C-5，C-6，C-7，and C-15，as well as $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlation of $\\mathrm { H } { - } 6 / \\mathrm { H } { - } 3 ^ { \\prime \\prime }$ . The similar ROESY data of 3,4 and 1 (Figure S2, Figure S3 and Figure 2A） suggested that they possessed similar relative configurations, with the $E$ geometry of the additional $\\Delta ^ { 2 \\prime \\prime \\prime \\prime , ( 3 \\prime \\prime \\prime ) }$ and $\\Delta ^ { 6 \\prime \\prime \\prime \\prime , ( 7 \\prime \\prime \\prime ) }$ double bonds in 3 and 4 being confirmed through analysis of the ROESY interaction (Figure S2 and Figure S3) between $\\mathrm { H } { - } 6 ^ { \\prime \\prime \\prime } / \\mathrm { H } { - } 8 ^ { \\prime \\prime \\prime }$ ， $\\mathrm { H } { - } 5 ^ { \\prime \\prime \\prime } / \\mathrm { H } .$ $9 ^ { \\prime \\prime \\prime }$ ， $\\mathrm { H } { - } 2 ^ { \\prime \\prime \\prime } / \\mathrm { H } { - } 4 ^ { \\prime \\prime \\prime \\prime }$ ,and $\\mathrm { H } { - } 1 ^ { \\prime \\prime \\prime } / \\mathrm { H } { - } 1 0 ^ { \\prime \\prime \\prime \\prime }$ . Similar to 1, the chiral centers of 3 and 4 were also located on the common parent nucleus A(Figure 2B) and ECD trends proved that 3,4 and 1 have consistent absolute configurations.Thus, the structure of 3 and 4 were elucidated, marking the inaugural instance of an oligomeric of lindenane- $C _ { 1 } { - } C _ { 6 } { - } C _ { 2 0 }$ geranylgeranyl toluquinone. ",
        "bbox": [
            518,
            473,
            915,
            885
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "Sarcglabtene E (5) was obtained as a colorless crystal, with a molecular formula of $\\mathrm { C } _ { 3 0 } \\mathrm { H } _ { 3 6 } \\mathrm { O } _ { 5 } ,$ determined by HRESIMS $\\left( m / \\right)$ $z ~ 4 9 9 . 2 4 5 5$ $[ \\mathbf { M } + \\mathbf { N a } ] ^ { + } )$ .The $^ 1 \\mathrm { H }$ NMR and HSQC spectra showed typical cyclopropane methylenes $[ \\delta _ { \\mathrm { H } } ~ 1 . 0 2 ~ ( \\mathrm { m } ) ^ { \\bar { } } / 0 . 1 0$ $\\mathrm { ( m ) }$ ] of the LS unit A(Table SS). Further HMBC correlations (Figure 3A) from $\\mathrm { H } _ { 2 }$ -15 to $\\mathrm { C } { \\cdot } 4$ $^ { \\prime } \\delta _ { \\mathrm { C } } 1 4 6 . 5 )$ and C-5 $\\left( \\delta _ { \\mathrm { C } } 1 2 5 . 0 \\right)$ ， and from H-6 ( $\\langle \\delta _ { \\mathrm { H } } 3 . 0 3 \\rangle$ ,d 3.0) to C-5 showed that the LS unit A in 5closely resembled unit A of chloranholide $\\mathbb { R } , ^ { 1 3 }$ with $\\Delta ^ { 5 , 6 }$ double bond replaced by $\\Delta ^ { * , 5 }$ double bond and C-4 hydroxyl by CH-6.The remaining 15-carbons unit B contained an $E .$ form $( \\delta _ { \\mathrm { H } } \\ 5 . 8 1 $ ，d 16.2; $\\delta _ { \\mathrm { H } }$ 5.38,dd 16.2,9.6) and terminal double bond $\\langle \\delta _ { \\mathrm { H } } 4 . 7 9 $ br $\\mathbf { s }$ $\\delta _ { \\mathrm { H } } 4 . 7 4$ , br s), three methyl groups $( \\delta _ { \\mathrm { H } } 0 . 8 4 ,$ d 6.6; $\\delta _ { \\mathrm { H } } 0 . 8 1$ ,d 6.6; $\\delta _ { \\mathrm { H } } 1 . 1 2 , s ,$ ),along with oneketo carbonyl group $( \\delta _ { \\mathrm { C } } 2 1 4 . 0 )$ . And, the key HMBC correlations from $\\mathrm { H } _ { 2 ^ { - } } \\mathrm { i } \\boldsymbol { \\mathsf { S } } ^ { \\prime }$ to $\\mathrm { C } { \\cdot } 3 ^ { \\prime }$ ， $\\mathrm { C } { \\cdot } 4 ^ { \\prime }$ and ${ \\mathrm { C } } { \\cdot } { 5 } ^ { \\prime }$ ，from $_ { \\mathrm { H } - 8 ^ { \\prime } }$ to $\\mathbf { C } { \\cdot } 9 ^ { \\prime }$ and from $\\mathrm { H } _ { 3 ^ { - 1 4 ^ { \\prime } } }$ to $\\mathrm { { C - 1 ^ { \\prime } } }$ ， ${ \\bf { C } } { \\cdot } 9 ^ { \\prime }$ $( \\delta _ { \\mathrm { C } } ~ 2 1 4 . 0 )$ and $\\mathrm { C } { - } 1 0 ^ { \\prime }$ along with $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlations of $\\mathrm { H } { - } 1 ^ { \\prime } / \\mathrm { H } _ { 2 } { - } 2 ^ { \\prime } / \\mathrm { H } _ { 2 } { - } 3 ^ { \\prime }$ ， $\\mathrm { H } { - } 5 ^ { \\prime } / \\mathrm { H } { - } 6 ^ { \\prime } /$ $\\mathrm { H } { - } 7 ^ { \\prime } / \\mathrm { H } _ { 2 } { - } 8 ^ { \\prime }$ and $\\mathrm { H } { - } 1 1 ^ { \\prime } / \\mathrm { H } { - } 7 ^ { \\prime }$ $\\mathrm { H } _ { 3 } – 1 2 ^ { \\prime }$ and $\\mathrm { H } _ { 3 } – 1 3 ^ { \\prime }$ revealed that the unit B resembled those of the germacrene $\\mathrm { D } , ^ { 1 4 }$ with the distinction being the presence of a $\\mathbf { C } { \\cdot } 9 ^ { \\prime }$ ketone group and the disappeared $\\Delta ^ { 1 / , 1 0 \\prime }$ . Moreover, the $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlation of $\\mathrm { H } _ { 2 } { - } 1 5 / \\mathrm { H } { - } 1 ^ { \\prime }$ and the HMBC correlations from $\\mathrm { H } _ { 3 } – 1 4 ^ { \\prime }$ to $C \\cdot$ 6, from H-6 to ${ \\mathrm { C } } { \\mathrm { - } } 1 0 ^ { \\prime }$ and $\\mathrm { { C - 1 ^ { \\prime } } }$ and from $\\mathrm { H } _ { 2 } { \\cdot } 1 5$ to $\\mathrm { { C - 1 ^ { \\prime } } }$ ， ${ \\bf C } { \\cdot } 2 { ' }$ and ${ \\mathrm { C } } { - } 1 0 ^ { \\prime }$ indicated that units A and B were bridged by a multiply substituted cyclohexene ring.The planar structure of 5 was thus delineated as an unprecedented lindenane and germarane sesquiterpenoid dimer. ROESY correlations (Figure 3A）of $\\mathrm { H } { - } 1 / \\mathrm { \\bar { H } } { - } 2 \\alpha / \\mathrm { \\bar { H } } { - } 3$ ， $\\mathrm { H } _ { 3 ^ { - } } 1 4 ^ { \\prime } / \\mathrm { H } { - } 6 / \\mathrm { H } _ { 3 ^ { - } } 1 4 / \\mathrm { H } { - } 2 \\beta$ and $\\mathrm { H } { - } 1 ^ { \\prime } /$ $\\mathrm { H } { - } 8 ^ { \\prime } \\alpha$ indicated that $\\mathrm { H } { - } 2 \\beta$ ，H-6, $\\mathrm { H } _ { 3 ^ { - } } \\mathrm { 1 4 }$ and $\\mathrm { H } _ { 3 ^ { - } } \\mathrm { l } 4 ^ { \\prime }$ were $\\beta$ oriented, while H-1, $_ \\mathrm { H } \\mathbf { \\cdot } 2 \\alpha$ ，H-3 and $\\mathrm { H } { - } 1 ^ { \\prime }$ was $\\alpha$ -oriented. Finally, The X-ray diffraction data $[ \\mathrm { C u ~ K } \\alpha$ radiation, Flack parameter 0.010(15), CCDC 2435061] of $\\pmb { 5 } ^ { 1 5 }$ (Figure 3B) not only unambiguously determined its absolute configuration as ",
        "bbox": [
            517,
            886,
            915,
            942
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            82,
            71,
            481,
            101
        ],
        "page_idx": 4
    },
    {
        "type": "image",
        "img_path": "images/0d038d590d3317a76124701abc4d1b172951ebaa4954a86b3accfa888967b2a8.jpg",
        "image_caption": [
            "Figure 3.Structural elucidation of 5.(A) Key 2D correlations and (B) X-ray crystallographic structure of 5. "
        ],
        "image_footnote": [],
        "bbox": [
            80,
            116,
            479,
            518
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            84,
            570,
            481,
            941
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "1R,3S,6S,8S,10S, $1 ^ { \\prime } S , ~ 7 ^ { \\prime } R , ~ 1 0 ^ { \\prime } F$ but also confirmed the skeleton as the first example of a lindenane-germacrene dimer. ",
        "bbox": [
            518,
            72,
            914,
            100
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Sarcglabtenes F (6) and G（7） had the same molecular formula, ${ \\mathrm { C } } _ { 2 5 } { \\mathrm { H } } _ { 3 2 } { \\mathrm { O } } _ { 4 }$ (10 degrees of unsaturation)，as determined by HRESIMS and $^ { \\mathrm { i 3 } } \\mathrm { C }$ NMR data.Analysis of their highly similar 1D NMR data revealed that 6 and 7 had the same planar structure. Their $^ 1 \\mathrm { H }$ NMR spectrum only shown a set of characteristic cyclopropane methylene signals $[ \\delta _ { \\mathrm { H } } \\ 0 . 8 3$ $\\mathbf { \\tau } ( \\mathbf { m } )$ and $\\delta _ { \\mathrm { H } } 0 . 6 7 ~ ( \\mathrm { m } ) \\big ]$ of LSs (Table S6),and the remaining ten carbons indicated that they were LS-monoterpene dimer.16 Comparison of the 1D NMR(Table S6) between 6, 7 and sarglalactone $\\mathrm { D }$ indicated that the LS unit in 6 and 7 are identical to unit A of sarglalactone D.17 This was also confirmed by the key HMBC correlations (Figure 4A） from $\\mathrm { H } _ { 3 } – 1 4$ to C-1, C-5, C-9,and C-10, from $\\mathrm { H } _ { 2 } { \\cdot } 1 5$ to C-3, C-4 and C-5, from $\\mathrm { H } _ { 3 } – 1 3$ to C-7, C-11 and C-12, from $\\mathrm { H } _ { 2 ^ { - 6 } }$ to C-7 and C-8，and from H-9 to C-8，as well as $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlations of $\\mathrm { H } { - } 1 / \\mathrm { H } _ { 2 } { - } 2 / \\mathrm { H } { - } 3$ and $\\mathrm { H } { - } 5 / \\mathrm { H } _ { 2 ^ { - } } 6$ .HMBC correlations from $_ { \\mathrm { H } - 8 ^ { \\prime } }$ to $\\mathrm { C } { \\cdot } 4 ^ { \\prime }$ and ${ \\bf { C } } { - 7 ^ { \\prime } }$ ，from $\\mathrm { H } { - } 9 ^ { \\prime }$ to $\\mathrm { { C - 1 ^ { \\prime } } }$ and ${ \\bf { C } } { - 7 ^ { \\prime } }$ ,from $_ \\mathrm { H - 1 0 ^ { \\prime } }$ to $\\mathbf { { C - 1 } ^ { \\prime } }$ $\\mathrm { C } { - } 4 ^ { \\prime }$ and $\\mathrm { { C } } { - } 7 ^ { \\prime }$ ,as well as $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlations of $\\mathrm { H } { - } 2 ^ { \\prime } / \\mathrm { H } _ { 2 } { - } 3 ^ { \\prime } / \\mathrm { H } { - } 4 ^ { \\prime } / \\mathrm { H } _ { 2 } { - } 5 ^ { \\prime } / \\mathrm { H } { - } 6 ^ { \\prime }$ (Figure 4A） indicated $\\alpha$ -campholenal as the monoterpene unit.18,19 ",
        "bbox": [
            517,
            100,
            915,
            265
        ],
        "page_idx": 4
    },
    {
        "type": "image",
        "img_path": "images/63072e4da3e421869b59a6926066f4067d9a66ddc8d1922de8753b206c1dc855.jpg",
        "image_caption": [
            "Figure 4. Structural elucidation of 6 and 7. (A) Key 2D correlations of 6 and 7,(B) experimental ECD spectra of 6 and 7,and (C) X-ray crystallographic structure of 6. "
        ],
        "image_footnote": [],
        "bbox": [
            515,
            276,
            915,
            588
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            518,
            652,
            914,
            761
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Moreover，the key HMBC correlations from $_ { \\mathrm { H } - 6 ^ { \\prime } }$ of monoterpene unit B to C-8 (6, $\\delta _ { \\mathrm { C } }$ 109.9；7, $\\delta _ { \\mathrm { C } }$ 109.7）and from H-9 ( $\\bullet , \\delta _ { \\mathrm { H } } 4 . 2 6 , \\mathrm { s } ; 7 , \\delta _ { \\mathrm { H } } 4 . 2 8 , \\mathrm { s } )$ of LS unit A to $\\mathrm { C } { - } 6 ^ { \\prime }$ (6, $\\delta _ { \\mathrm { C } }$ 105.8；7, $\\delta _ { \\mathrm { C } }$ 106.0）indicated that sesquiterpenoid and monoterpene units were fused by a unique 1,3 dioxolane ring through acetalization, similar to sarglalactone D.17 ",
        "bbox": [
            518,
            765,
            915,
            846
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "The relative configuration of 6 and 7 was readily established using ROESY data (Figure 4A). ROESY correlations among 6, 7 and sarglalactone D were similar, confirming that the relative configuration of unit A in 6 and 7 was consistent with that of sarglalactone D. The key to determining their relative configuration lay in $_ { \\mathrm { H } - 6 ^ { \\prime } }$ and $_ { \\mathrm { H } - 4 ^ { \\prime } }$ of the new polymerization unit B.The relative configuration of $_ { \\mathrm { H } - 6 ^ { \\prime } }$ of 6 and 7 was elucidated by ROESY correlations of $\\mathrm { H } _ { 3 ^ { - } } 1 4 / \\mathrm { H } { - } 9 / \\mathrm { H } { - } 6 ^ { \\prime }$ ，which indicated that $_ { \\mathrm { H } - 6 ^ { \\prime } }$ was $\\beta$ -oriented.However，the stereochemistry at the relative configurations of $_ { \\mathrm { H } - 4 ^ { \\prime } }$ cannot be assigned due to the lack of definitive ROESY correlations. Further analysis of the above relative configurations,similar CD spectra (Figure 4B)，along with slight NMR differences around the monoterpene unit of 6 and 7,indicated they were $\\mathrm { C } { - } 4 ^ { \\prime }$ isomers, thus the next task was to determine the relative configuration of $\\mathrm { C } { - } 4 ^ { \\prime }$ .After testing various solvents and crystallization conditions,single crystals of 6 were obtained in a methanol- $\\mathbf { \\cdot H } _ { 2 } \\mathbf { O }$ mixture at $4 ~ ^ { \\circ } \\mathrm { C }$ .X-ray crystallography results (Figure 4C） not only determined the relative configuration at $C ^ { - 4 ^ { \\prime } }$ of 6 as shown in Figure 1，but also established the absolute configuration of 6 as 1R,3S,5S,8S,9S,10S, $4 ^ { \\prime } R ,$ $5 ^ { \\prime } S$ （ $\\mathrm { { C u } }$ $\\mathrm { K } \\alpha$ radiation，Flack parameter 0.01(4)，CCDC 2435062).15 As a $\\mathrm { C } { \\cdot } 4 ^ { \\prime }$ isomer of 6, the absolute configuration of 7 was determined to be 1R,3S,5S,8S,9S,10S, $\\bar { 4 } ^ { \\prime } S$ ${ \\boldsymbol { 5 ^ { \\prime } } } { \\boldsymbol { S } } .$ Therefore, the absolute configuration of 6 and 7, representing the first examples of a lindenane-campholenal dimer，were established. ",
        "bbox": [
            518,
            847,
            915,
            942
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            84,
            72,
            481,
            346
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Sarcglabtene H (8） had the same molecular formula, $\\mathrm { C _ { 4 8 } H _ { 5 4 } O _ { 1 2 } } ,$ as spirolindemer $\\mathbf { B } , ^ { 2 0 }$ as determined by the $\\left( + \\right)$ -HRESIMS ion at $m / z \\ 8 4 5 . 3 5 0 8$ $[ \\mathbf { M } \\ + \\ \\mathbf { N a } ] ^ { + }$ (calcd for $\\mathrm { C } _ { 4 8 } \\mathrm { H } _ { 5 4 } \\mathrm { O } _ { 1 2 } \\mathrm { N a }$ ,845.3507). The 1D NMR spectrum (Table S7) of 8 was similar to that of spirolindemer $\\mathrm { A } _ { r }$ ，except for the absence of the $\\Delta ^ { 5 \\prime ( 6 \\prime ) }$ double bond and the 3,4-dihydro-2Hpyran ring in spirolindemer A and the presence of a Δ6() double bond, an $E$ -configured $\\Delta ^ { 1 5 \\prime \\prime , ( 4 \\prime \\bigprime ) }$ double bond, $5 \\beta \\mathrm { - H }$ and a $\\mathrm { C } { \\cdot } 8 ^ { \\prime }$ keto-carbonyl group in 8.This difference was confirmed by the $\\mathrm { ^ { 1 } H - ^ { 1 } H }$ COSY correlations (Figure SA） of $_ { \\mathrm { H } - \\mathsf { S } ^ { \\prime } }$ $[ \\delta _ { \\mathrm { H } }$ ",
        "bbox": [
            84,
            347,
            479,
            485
        ],
        "page_idx": 5
    },
    {
        "type": "image",
        "img_path": "images/4cab9e2bc7d0b5065d6af17bc6a8e78e4f2f7ea142ccea6ead13d1ef518689dd.jpg",
        "image_caption": [
            "Figure 5.Structural elucidation of 8.(A-C) Key 2D correlations of 8 and (D） experimental and calculated ECD spectra of 8. "
        ],
        "image_footnote": [],
        "bbox": [
            82,
            497,
            477,
            752
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "2.13, d $\\left( 6 . 0 \\right) \\mathrm { ] } / \\mathrm { H } { - 6 ^ { \\prime } }$ $[ \\delta _ { \\mathrm { H } } 6 . 3 9 .$ ,d (6.0)], the HMBC correlations from $_ { \\mathrm { H } - 6 ^ { \\prime } }$ to ${ \\bf { C } } { - 7 ^ { \\prime } }$ $\\langle \\delta _ { \\mathrm { C } } 1 3 8 . 5 \\rangle$ and $C – 8 ^ { \\prime }$ $( \\delta _ { \\mathrm { C } } 1 9 8 . 3 )$ and from H$1 5 ^ { \\prime \\prime }$ $\\left[ \\delta _ { \\mathrm { H } } \\ 5 . 5 9 , \\ s \\right]$ to $\\mathrm { C } { \\cdot } 4 ^ { \\prime \\prime }$ $^ { \\prime } \\delta _ { \\mathrm { C } } ~ 1 4 3 . 8 )$ ， along with the ROESY correlations (Figure SB and 5C) of $\\mathrm { H } { - } 1 5 ^ { \\prime \\prime } / \\mathrm { \\bar { H } } { - } 6 ^ { \\prime \\prime }$ and $\\mathrm { H } { - } 5 ^ { \\prime } / \\mathrm { H } .$ $2 ^ { \\prime } \\beta$ .The absolute configuration of 8 was determined based on comparative analysis of calculated and experimental ECD curves (Figure SD) as wellas biogenic synthesis pathways.3,9,12 Thus,the structure of 8,which represented the first LS trimer with an opened 3,4-dihydro-2H-pyran ring, was determined. ",
        "bbox": [
            82,
            817,
            481,
            942
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Sarcglabtenes I (9),J(10）and K(11） shared the same molecular formula $\\left( \\mathbf { C } _ { 3 2 } \\mathbf { H } _ { 3 8 } \\mathbf { O } _ { 8 } \\mathbf { N } \\mathbf { a } \\right)$ ，asrevealed by the HRESIMS，which was 2 mass units more than that of spirolindemer $\\mathrm { A } ^ { 2 0 }$ Comparison of 1D NMR data of 9 (Table S8) with those of spirolindemer A indicated the replacement of the C-9 carbonyl group in spirolindemer A by a C-9 hydroxy group in 9,as supported by the key HMBC correlation (Figure 6A） from $\\mathrm { C H } _ { 3 ^ { - 1 4 } }$ to C-9 $( \\delta _ { \\mathrm { C } } 7 6 . 4 )$ . The ROESY correlation (Figure 6A) of $\\mathrm { H } { - } 1 / \\mathrm { H } { - } 9$ indicated that the relative configuration of the C-9 hydroxy group was $\\beta$ -oriented. The ECD curves of 9 were in good agreement with those of our previously reported spirolindemer A (Figure 6B).20 Therefore, the absolute structures of 9 were defined.Analysis of NMR data of 10 and 11(Table S9） revealed that their structures were closely related to that of 9. Compared with 9，the disappearance of the terminal double bond and the appearance of the $\\mathrm { C H } _ { 3 }$ -15 and $\\Delta ^ { 4 , ( 5 ) }$ double bonds in 10 were confirmed by key HMBC correlations (Figure S4） from $\\mathrm { H } _ { 3 }$ -15 $( \\delta _ { \\mathrm { H } } 1 . 7 1 $ br s) to C-4 $\\left( \\delta _ { \\mathrm { C } } \\ 1 3 4 . 7 \\right)$ and C-5 $\\left( \\delta _ { \\mathrm { C } } \\ 1 3 2 . 5 \\right)$ ，whilein compound 11, the only difference was that the $\\Delta ^ { 7 \\prime , ( 1 1 \\prime ) }$ double bond is in the E configuration,which is consistent with the previously reported relationship between henriol $\\textrm { C }$ and shizukaol $\\mathrm { B } ^ { 2 1 }$ and was also confirmed by the downfield shifts of the proton signals at $\\delta _ { \\mathrm { H } } 6 . 7 1$ $\\left( \\mathsf { s } , \\mathrm { H } \\cdot 6 ^ { \\prime } \\right)$ and 2.40 (s, $\\mathrm { H } _ { 3 } – 1 3 ^ { \\prime } \\big >$ compared with the corresponding proton resonances of 9 $[ \\delta _ { \\mathrm { H } }$ 6.39 (s, $\\mathrm { H } { - } 6 ^ { \\prime } $ ,2.09 (s, $\\mathrm { H } _ { 3 } { - } 1 3 ^ { \\prime } ) \\underline { { \\cdot } }$ ,as well as the differences in the chemical shifts of $\\mathrm { { C } } { - } 1 1 ^ { \\prime }$ $\\langle \\delta _ { \\mathrm { C } } ~ 1 3 7 . 5 )$ and $C – 8 ^ { \\prime }$ $\\left( \\delta _ { \\mathrm { C } } \\ 2 0 2 . 3 \\right)$ compared with those of 9 $\\left[ \\delta _ { \\mathrm { C } } 1 3 8 . 2 \\left( \\mathrm { C } \\cdot 1 1 ^ { \\prime } \\right) \\right.$ and $\\delta _ { \\mathrm { C } }$ 198.6 (C$8 ^ { \\prime } \\mathit { \\check { \\Psi } }$ )]. The ROESY correlations (Figure S4 and SS) and ECD curves (Figure 6B) of 10 and 11 were in good agreement with those of 9 (Figure 6). Therefore, the absolute structures of 10 and 11 were defined. ",
        "bbox": [
            518,
            72,
            915,
            513
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Sarcglabtene L (12),a white,amorphous,purified powder, had the molecular formula $\\mathrm { C } _ { 3 0 } \\mathrm { H } _ { 3 2 } \\mathrm { O } _ { 8 } ,$ based on its HRESIMS data.Its 1D NMR(Table SiO) data showed similarities to those of our previously reported sarglalactone $\\mathrm { D } , ^ { 1 7 }$ except for a 1,3-dioxolane ring being replaced by an ester bond (C-9, $\\delta _ { \\mathrm { C } }$ 77.0; ${ \\bf { C } } { \\cdot } 9 ^ { \\prime }$ ， $\\delta _ { \\mathrm { C } }$ 176.8)and $\\beta$ OH-8 (C-8, $\\delta _ { \\mathrm { C } }$ 105.1) in 12. This conclusion was confirmed by the HMBC correlations (Figure 7A) from H-9 to C-8 and $\\mathbf { C } { \\cdot } 9 ^ { \\prime }$ . Furthermore，according to reference,22 the $\\alpha$ -orientation of $\\mathrm { C } ( 8 ) { \\mathrm { - O H } }$ corresponded with the proton chemical shift of $\\mathrm { C H } _ { 3 ^ { - 1 4 } }$ in a range of $0 . 4 2 \\substack { - 0 . 6 7 }$ ppm, while a shift in the range of 0.82-1.47 ppm for $\\mathrm { C H } _ { 3 ^ { - 1 4 } }$ corresponded to the $\\beta$ -orientation of $\\mathrm { C } ( 8 ) { \\mathrm { - O H } }$ ，Thus，the proton chemical shift of $\\mathrm { C H } _ { 3 ^ { - } } 1 4$ $\\left( \\delta _ { \\mathrm { H } } \\ 1 . 0 3 , \\ s \\right)$ in 12 indicated that the $\\mathrm { C } ( 8 ) { \\mathrm { - O H } }$ was $\\beta$ -orientation. The absolute configuration of 12 was assigned by applying the exciton chirality CD method (Figure 7B） and known LSs with similar biogenetic pathways. 3,9,12 ",
        "bbox": [
            518,
            515,
            915,
            750
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "The novel polymeric units and rare polymerization forms of hetero-oligomers $^ { 1 - 7 }$ prompted us to summarize their plausible biosynthetic pathways (Scheme 1).According to their structures,chloranthalactone A was considered as the precursor of lindenane unit,8,23 which underwent oxidation, reduction，and lactonization to form diverse derivatives as intermediates for subsequent transformations with other nonLS units.24 In path A, an oxygenated $[ 4 + 2 ]$ cycloaddition at nonclassical positions,withthe $\\Delta ^ { 7 ( 1 1 \\bar { ) } , 8 ( \\mathrm { O } ) }$ of i acting as the diene moiety and the $\\Delta ^ { 1 5 \\prime , ( 4 \\prime ) }$ of another i acting as the dienophile moiety, produced ii, which was equipped with the same oxaspiro[4.S]decane as previously reported spirolindemer A.20 Spicatulide G underwent redox reactions to form intermediate ii.25 The coisolated 13 was oxidized to generate intermediate 2-(Geranylgeranyl)-6-methyl-1,4-benzoquinone.26 Intermediate ii with $\\Delta ^ { 1 5 ^ { \\prime } 4 ) , 5 ( 6 ) }$ diene moieties reacted with ii containing two $\\Delta ^ { 5 ( 6 ) }$ and $\\Delta ^ { 2 ( 3 ) }$ dienophile moieties via $[ 4 + 2 ]$ cycloaddition to produce 1 and 2, respectively.' Similar to 1 and 2,intermediate ii and 2-(Geranylgeranyl)-6-methyl1,4-benzoquinone underwent $[ 4 + 2 ]$ cycloaddition to generate 3 and 4. In_path B,chloranthalactone E reacted with $\\alpha$ campholenal18,19 9 via acetalization to produce 6 and 7 with a rare 1,3 dioxolane ring as sarglalactone D.17 Intermediate iv reacted with the oxidation product $\\mathbf { v }$ of germacrene $\\mathrm { D } ^ { 1 4 }$ through a $[ 4 ~ + ~ 2 ]$ cycloaddition to yield 5 with a unique skeleton. ",
        "bbox": [
            518,
            750,
            914,
            941
        ],
        "page_idx": 5
    },
    {
        "type": "image",
        "img_path": "images/7a764615fffc12d5e09a0b9ecd3521b0d5ac9a0d462ad81eff3662a88cf3c88d.jpg",
        "image_caption": [
            "Figure 6. Structural elucidation of 9. (A) Key 2D corelations of 9 and (B) experimental ECD spectra of ${ \\bf 9 - 1 1 }$ "
        ],
        "image_footnote": [],
        "bbox": [
            130,
            75,
            868,
            348
        ],
        "page_idx": 6
    },
    {
        "type": "image",
        "img_path": "images/5e9640358b4cd675f9e6a5f5c4d99d7a251b5912b8001411fd81b24788f44872.jpg",
        "image_caption": [
            "Figure 7. Structural elucidation of 12.(A) Key 2D correlations of 2 and (B) experimental ECD and UV spectra of 12. "
        ],
        "image_footnote": [],
        "bbox": [
            85,
            386,
            477,
            765
        ],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            84,
            817,
            479,
            942
        ],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            517,
            383,
            914,
            425
        ],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "In recent years, the traditional herbal medicine S. glabra has been widely used to treat various cancer types， including pancreatic， gastric， rectal, liver，and esophageal cancer.10,29 This prompted an evaluation of the cytotoxic activities of sarcglabtenes $_ { \\mathrm { A - L } }$ (1-12). As shown in Figure 8A, unique hetero-LS trimers $\\mathbf { 1 - 4 }$ exhibited cytotoxic activity，with 4 showing an $\\mathrm { I C } _ { 5 0 }$ value of $4 . 0 6 \\pm 0 . 1 1 \\mu \\mathrm { M }$ against MDA-MB231 cells,a highly metastatic breast caner cell line,which was 3-fold more potent than the positive control DDP. Thus, 4 was selected for further investigation.Initially，we investigated whether 4 affected the epithelial-mesenchymal transition (EMT） process in these cells. Scratch assays showed that 4 could concentration-dependently downregulate the migratory capacity of MDA-MB-231 cels (Figure 8B). Western blotting analysis also confirmed that 4 inhibited the phosphorylation of JNK,Erk，MEK, and p38 proteins in the MAPK pathway (Figure 8C and Figure S7), while upregulating E-cadherin and downregulating the expression of N-cadherin and zonula occudens-1 (ZO-1) (Figure 8D and Figure S8). By inhibiting the phosphorylation and activation of the MAPK pathway, 4 disrupted the EMT process, thereby suppressing cell migration and invasion. Additionally,Annexin V/PI staining and flow cytometry analysis demonstrated that 4 significantly induced apoptosis (Figure 8E).Western blotting results also showed that 4 promoted the cleavage of caspase-dependent apoptotic proteins (caspase-3，caspase-9，PARP） and upregulated the expression of pro-apoptotic protein Bax while downregulating the antiapoptotic protein Bcl-2 (Figure 8F and Figure S9), thereby accelerating apoptosis_in MDA-MB-231 cels. Drug affinity responsive target stability (DARTS） experiments indicated that 4 bound to proteins in the $4 0 { - } 5 0 \\ \\mathrm { k D a }$ range (Figure S6). This molecular weight range includes the Erk protein that activates and regulates various transcription factors through phosphorylation in the MAPK pathway， promoting cellproliferaodprotecingcellsfomappoUsing DARTS-Western bloting, we confrmed significant interaction between 4 and Erk protein (Figure 8G and Figure S10). ",
        "bbox": [
            517,
            422,
            915,
            941
        ],
        "page_idx": 6
    },
    {
        "type": "image",
        "img_path": "images/7ddc87c19f6d74171439be12a6b3b01cc69a00892b24ac44ce2f9bad2cdd5e18.jpg",
        "image_caption": [
            "Figure 8.Compound 4 interacts with $\\mathrm { E r k }$ to inhibit the MAPK pathway,disrupt EMT,reduce tumor cell migration and invasion,and induce apoptosis. (A) Calculation of $\\mathrm { I C } _ { 5 0 }$ values for 1-12. (B) Cellscratch test was performed to measure the migration ability of 4 and MDA-MB-231 cells (C)Expreevesopataeaedpotesf4treant.(D)Expresvelsoelatedrotensft (E)FlowomesotltsFExesesotest (G)DARTS-Westebloteerimentalvalidatiooftheiterbdinteractioof4ithErkprote.(H)CETaalysisftcear binding between 4and Erk. Protein levels were investigated at diffrent temperatures under the treatment of 4 $( 4 \\mu \\mathbf { M } )$ in MDA-MB-231 cells. $\\left( \\mathrm { I } , \\mathrm { J } \\right) ,$ Interactions based on molecular docking studies between Erk 1 protein (PDB: 4QTB） with 4. "
        ],
        "image_footnote": [],
        "bbox": [
            84,
            70,
            914,
            615
        ],
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "Cellular thermal shift assay (CETSA） further validated that 4 enhanced the thermal stability of Erk protein, confirming their direct interaction (Figure 8H).Molecular docking results also supported this finding (Table S11, Figure 8I, Figure 8J, Figure S11 and Figure S12). In summary, 4 bound to Erk protein, inhibited the activation of the MAPK pathway, disrupted the EMT process, suppressed tumor cell migration and invasion, and induced apoptosis， thus providing promising evidence supporting its application as a lead compound for the development of novel Erk inhibitors. ",
        "bbox": [
            84,
            722,
            479,
            868
        ],
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "In summary， sarcglabtenes A-G (1-7)，seven lindenanebased sesquiterpenoid hetero-oligomers with six unprecedented skeletons, along with five new biosynthetic analogues (8-12)，were discovered from S. glabra,a famous and commonly used traditional Chinese Medicine. Structurally, they represent the first examples of lindenane-based heterooligomers with geranyl homogentisic acid $\\mathbf { ( 1 / 2 ) }$ ， geranylgeranyl $p$ -toluquinone $\\left( 3 / 4 \\right)$ ， germarane (5)，campholenal $( 6 / 7 )$ derivatives,greatly enriching the structural diversity of the LS scaffold. Considering the diversity of nonlindenane components in plants containing lindenane,additional LS heterooligomers remain to be discovered,which will provide new directions for the future development of LSs.Notably, these heterosesquiterpenoid oligomeric scaffolds derived from lindenane represent a unique class of natural compounds that target Erk,a critical protein kinase involved in cell signaling pathways.When dysregulated,Erk is intricately linked to cancer progression，making it an increasingly critical therapeutic target in oncology. Thus, the discovery of these compounds not only highlights the great potential of this emerging group of lindenane-based oligomers but also provides a promising source for the development of new Erk inhibitors as anticancer lead compounds, serving as a rationale for further research and application of S. glabra as an anticancer drug. ",
        "bbox": [
            84,
            870,
            479,
            942
        ],
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            518,
            723,
            914,
            942
        ],
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            84,
            72,
            479,
            141
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "EXPERIMENTALSECTION ",
        "text_level": 1,
        "bbox": [
            84,
            156,
            298,
            170
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "General Experimental Procedures.Melting points were measured using a RY-1G apparatus.Optical rotations were measured in methanol through a JASCO P-1020 polarimeter. The UV absorbance was determined on a Shimadzu UV-24So UV-vis spectrophotometer.IR spectra were recorded ona Nicolet iS1O FTIR and Bruker Tensor-27 infrared spectrophotometer. The JASCO J810 spectrometer was used to record the ECD spectra (measured in methanol at $2 5 ~ ^ { \\circ } \\mathrm { C }$ ).NMR spectra were recorded on the Bruker AV600 NMR instrument (Bruker,Karlsruhe,Germany）at $2 5 ~ ^ { \\circ } \\mathrm { C }$ TMS was used as the internal standard,and $\\mathrm { C D C l } _ { 3 }$ MeODor $\\mathrm { C D } _ { 3 } \\mathrm { C O O D }$ as solvents.Structural assignments were completed through additional information from $\\mathrm { \\ g C O S Y } .$ ，gHSQC，gHMBC，and ROESY experiments.HRESIMS data were acquired on an Agilent 652oB UPLC- $\\mathrm { Q } \\mathrm { - }$ TOF instrument.Preparative HPLC was performed on the Shimadzu LC-20AR system with a UV detector (SPD-20A)，which was equipped with an Ultimate XB-C18 column ( $2 5 0 \\ \\mathrm { \\ m m } \\times 2 0 \\ \\mathrm { \\ m m }$ i.d., $5 ~ \\mu \\mathrm { m } )$ witha flow rate of $1 0 . 0 \\ \\mathrm { \\ m L / m i n }$ .The samples were analyzed by HPLC using an Agilent 110O system equipped with_a DAD detector and an Agilent ZORBAX Eclipse XDBC18 column [5 $\\mu \\mathrm { m } ,$ $\\mathrm { 1 , 1 5 0 \\times 4 . 6 \\ m m }$ (i.d.)] or a Phenomenex Cellulose-2 chiral column (5 μm, $2 5 0 \\times 4 . 6 ~ \\mathrm { m m }$ )，withaflowrate of $1 \\ \\mathrm { m L } / \\mathrm { m i n }$ in either $\\mathrm { C H } _ { 3 } \\mathrm { O H } / \\mathrm { H } _ { 2 } \\mathrm { O }$ or $\\mathrm { C H } _ { 3 } \\mathrm { C N } / \\mathrm { H } _ { 2 } \\mathrm { O }$ solvent systems. Column chromatography(CC） separations were carried out using silica gel (100-200 mesh and 20o-300 mesh；Qingdao Haiyang Chemical Co.,Ltd., Qingdao,China),MCI (Mitsubishi, Japan),YMC-Gel RP-Ci8(50 $\\mu \\mathrm { m }$ ；YMC，Milford，MA)，and Sephadex LH-20 $( 4 0 - 7 0 \\ \\mu \\mathrm { m } ; $ Amersham Pharmacia Biotech AB,Uppsala，Sweden).The thinlayer chromatography (TLC）analysis was performed on precoated silica gel GF254 plates. ",
        "bbox": [
            84,
            175,
            481,
            532
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Plant Material. The roots of Sarcandra glabra (Thunb.) Makino were collected in Sanming $2 6 ^ { \\circ } 1 5 ^ { \\prime } \\mathrm { ~ N ~ }$ $1 1 7 ^ { \\circ } 2 7 ^ { \\prime } \\mathrm { ~ E ~ }$ ),Fujian Province, People's Republic of China,in August 2019.Identification of the plant samples was completed by Prof.Mian Zhang at China Pharmaceutical University.A voucher specimen (no.20190802） was deposited at the Department ofNatural Medicinal Chemistry at China Pharmaceutical University. ",
        "bbox": [
            82,
            535,
            479,
            620
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Extraction and Isolation.The powder of dried roots of S. glabra $( 2 0 \\mathrm { k g } )$ was extracted for three times with $9 5 \\%$ EtOH under reflux (3 $\\mathbf { h } , 2 \\mathbf { h } , 2 \\mathbf { h } )$ ).The filtrate was concentrated under vacuum to obtain the crude extract $( 9 6 0 \\mathrm { g } )$ ，which was then suspended in water and partitioned with $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 }$ The $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 }$ extracts $\\left( 3 3 0 \\ \\mathrm { g } \\right)$ were separated by silica gel column chromatography through gradient elution of $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 } / \\mathrm { C H } _ { 3 } \\mathrm { O H }$ (from 100:1 to 2:1) to yield eight major fractions $\\left( \\mathrm { F r } . 1 - 8 \\right)$ Fr.3 $( 1 7 . 5 \\ \\mathrm { \\ g } )$ was chromatographed over an MCI gel column $\\mathrm { ( C H _ { 3 } O H / H _ { 2 } O }$ from S0:50 to 100:0) to give ten fractions $\\left( \\mathrm { F r } . 3 \\mathrm { A } - 3 \\mathrm { J } \\right) ,$ .Fr.3C $( 2 . 5 \\ { \\mathrm { g } } )$ was_partitioned on a Sephadex LH-20 eluted with $\\mathrm { C H } _ { 3 } \\mathrm { O H }$ and purified by reversed-phase preparative HPLC using $7 0 \\%$ MeOH to yield 6 ( $2 \\mathrm { m g } , 3 1 \\mathrm { m i n } ,$ and7 $\\cdot 1 . 5 \\mathrm { m g } , 3 3$ min).Fr. 3I $( 1 . 9 \\mathrm { g } )$ was partitioned on a Sephadex LH-20 eluted with $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 } / \\mathrm { C H } _ { 3 } \\mathrm { O H }$ (1:1)and purifed by reversed-phase preparative HPLC using $9 5 \\%$ MeOH to yield 5 ( $3 \\ \\mathrm { m g } , 2 4 \\ \\mathrm { m i n }$ ).Fr.3H $( 1 . 2 ~ \\mathrm { g } )$ was partitioned ona Sephadex LH-2O eluted with $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 } / \\mathrm { C H } _ { 3 } \\mathrm { O } \\mathrm { \\bar { H } }$ (1:1)and purified by reversed-phase preparative HPLC using $1 0 0 \\%$ MeOH to yield 13( $( 4 0 \\mathrm { m g } , 1 3 \\mathrm { m i n } )$ .Fr.3J $( 2 \\mathrm { ~ g ) }$ was partitioned on a Sephadex LH-20 eluted with $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 } / \\mathrm { C H } _ { 3 } \\mathrm { O H }$ (1:1) and purified by reversed-phase preparative HPLC using $9 8 \\%$ $\\mathrm { C H } _ { 3 } \\mathrm { C N } / \\mathrm { H } _ { 2 } \\mathrm { O }$ to yield 4 $\\left( 1 0 ~ \\mathrm { \\ m g } , ~ 1 9 ~ \\mathrm { \\ m i n } \\right)$ ）and3 $( 3 0 ~ \\mathrm { \\ m g } , ~ 2 2 ~ \\mathrm { \\ m i n } )$ Fr.4 $( 4 0 \\textrm { ‰}$ was chromatographed over an MCI gel column $( \\mathrm { C H _ { 3 } O H } / \\mathrm { H _ { 2 } O }$ from 30:70 to 100:0) to give four fractions (Fr.4A-4D).Fr.4B $( 9 \\ { \\ g } )$ was chromatographed on an ODS column using $\\mathrm { C H } _ { 3 } \\mathrm { O H } / \\mathrm { H } _ { 2 } \\mathrm { O }$ (50:50 to 100:0） to yield four fractions (Fr.4B1-4B4).Fr.4B3 $\\left( 1 . 9 \\ \\mathrm { \\ g } \\right)$ was separated over a Sephadex LH-20 gel ( $\\mathrm { C H } _ { 3 } \\mathrm { O H } )$ to obtain eight fractions (Fr.4B3A-Fr.4B3H).Fr.4B3F $\\left( 2 0 7 . 2 ~ \\mathrm { m g } \\right)$ was chromatographed by HPLC with $\\mathrm { C H } _ { 3 } \\mathrm { O H } / \\mathrm { H } _ { 2 } \\mathrm { O }$ (80:20) to yield 9 ( $3 0 ~ \\mathrm { m g } , 4 8$ min),11 ( $\\mathrm { ~ \\zeta ~ } 5 \\mathrm { ~ m g } , 5 0 \\mathrm { ~ m i n } ,$ and10 $\\left( 3 \\mathrm { \\ m g } , 5 5 \\mathrm { \\ m i n } \\right)$ ).Fr.4B4 $( 2 . 0 \\ \\mathrm { g } )$ was separated over a Sephadex LH-20 gel $\\mathrm { ( C H _ { 2 } C l _ { 2 } / C H _ { 3 } O H = 1 / \\bar { 1 } ) }$ ）to obtain seven fractions (Fr.4B4A-Fr.4B3G).Fr.4B4C $\\left( 1 1 0 . 1 ~ \\mathrm { m g } \\right)$ was chromatographed by HPLC with $\\mathrm { C H } _ { 3 } \\mathrm { O H } / \\mathrm { H } _ { 2 } \\mathrm { O }$ (85:15) to yield 12 $( 4 \\mathrm { ~ m g } , \\ 3 2 \\mathrm { ~ m i n } )$ .Fr.4D $( 8 \\ { \\bf { g } } )$ was chromatographed on an ODS column using $\\mathrm { C H } _ { 3 } \\mathrm { O H } / \\mathrm { H } _ { 2 } \\mathrm { O }$ (50:50 to l0o:0) to yield four fractions (Fr.4D1-4D4). Fr.4D4 $( 2 . 7 \\ g )$ was partitioned into nine subfractions (Fr. 4D4A - 4D4I) using Sephadex LH-20 eluted with $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 } /$ $\\mathrm { C H } _ { 3 } \\mathrm { O H }$ (1:1). Fr. 4D4I $\\left( 1 3 5 . 2 \\mathrm { m g } \\right)$ was chromatographed by HPLC with $\\mathrm { C H } _ { 3 } \\mathrm { C N } / \\mathrm { H } _ { 2 } \\mathrm { O }$ (80:20） to yield 2 $( 1 . 6 ~ \\mathrm { m g } , 2 \\bar { 5 } ~ \\mathrm { m i n } )$ ）and1 (2.5 mg, $3 0 \\ \\mathrm { m i n } \\dot { }$ .Fr.5 $( 8 3 . 9 \\ \\mathrm { g } )$ was chromatographed over an MCI gel column $\\mathrm { ( C H _ { 3 } O H / H _ { 2 } O }$ from 50:50 to 100:0)to give 12 fractions (Fr.5A-SL). Fr.5G $( 8 . 4 \\ : \\mathrm { g } )$ was chromatographed on an ODS column using $\\mathrm { C H } _ { 3 } \\mathrm { O H } / \\mathrm { H } _ { 2 } \\mathrm { O }$ (50:50 to 100:0）to yield eight fractions $\\left( \\mathrm { F r . } 5 \\mathrm { G 1 } - 5 \\mathrm { G 8 } \\right)$ . Fr.5G7 $( 2 . 4 ~ \\mathrm { g } )$ was partitioned on a Sephadex LH20 eluted with $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 } / \\mathrm { C H } _ { 3 } \\mathrm { O H }$ (1:1) and purifed by reversed-phase preparative HPLC using $\\mathrm { C H } _ { 3 } \\mathrm { C N } / \\mathrm { H } _ { 2 } \\mathrm { O }$ (55:45) to yield 8 ( $\\beta \\ \\mathrm { m g } , 4 2$ min). ",
        "bbox": [
            84,
            620,
            481,
            942
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            518,
            71,
            914,
            320
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Sarcglabtene A (1). yellowish gum; $[ \\alpha ] _ { \\mathrm { D } } ^ { 2 5 } = - 6 5 . 1$ $\\mathit { \\check { c } } = 0 . 1 0$ in MeOH); $^ { 1 } \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S1; IR $\\nu _ { \\operatorname* { m a x } } = 3 7 0 8$ 2935, 2857,1725,1676,1599,1431,1360,1297,1237,1163,1029,996, 910, $7 2 8 ~ \\mathrm { c m ^ { - 1 } }$ ; UV $\\scriptstyle ( { \\mathrm { M e O H } } )$ $\\lambda _ { \\operatorname* { m a x } }$ $( \\log \\varepsilon ) = 2 3 5$ (4.21),293 (0.48) nm; CD $\\left( \\mathrm { { M e O H } } \\right)$ : $\\left( \\Delta \\varepsilon \\right) = 2 1 7$ $\\left( - 4 . 6 3 \\right)$ ,276 (2.00),333 $\\left( - 1 . 5 7 \\right)$ nm； $\\left( + \\right)$ -HRESIMS: $m / z$ 887.3976 $[ \\mathbf { M \\Sigma } + \\mathbf { \\Sigma } \\mathbf { N } \\mathbf { a } ] ^ { + }$ (calcd for $\\mathrm { C _ { 5 1 } H _ { 6 0 } O _ { 1 2 } N a } ,$ 887.3977). ",
        "bbox": [
            517,
            321,
            915,
            407
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Sarcglabtene B (2). yellowish gum; $[ \\alpha ] _ { \\mathrm { D } } { } ^ { 2 5 } = - 6 2 . 2$ 0 $c = 0 . 1 0$ inMeOH); $^ { 1 } \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S2; IR: $\\nu _ { \\operatorname* { m a x } } = 3 4 7 2$ ,2932,2866,1728,1679,1638,1594,1438,1378,1301,1227,1116,1095,1033,1005, 906, $7 2 8 ~ \\mathrm { c m } ^ { - 1 }$ ; UV $\\scriptstyle ( { \\mathrm { M e O H } } )$ $\\ l _ { \\mathrm { m a x } } \\left( \\log \\varepsilon \\right) = 2 2 5$ (4.17),288(1.39） nm; CD $\\left( \\mathrm { { M e O H } } \\right)$ ： $( \\Delta \\ \\varepsilon ) = 2 1 9$ $( - \\bar { 4 } . 3 5 )$ ,273 (1.05),333 $\\mathrm { ( - 0 . 8 8 ) \\ n m ; }$ $\\left( + \\right)$ -HRESIMS: $m / z 8 8 7 . 3 9 7 6 [ \\mathrm { M } + \\mathrm { N a } ] ^ { + }$ (calcd for$\\mathrm { C _ { 5 1 } H _ { 6 0 } O _ { 1 2 } N a } ,$ 887.3977).",
        "bbox": [
            518,
            407,
            915,
            495
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Sarcglabtene $c$ (3). yellowish gum; $[ \\alpha ] _ { \\mathrm { D } } { } ^ { 2 5 } = - 6 2 . 6$ $\\mathit { \\check { c } } = 0 . 1 0$ inMeOH); $^ { 1 } \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR datasee Table S3; IR: $\\nu _ { \\mathrm { m a x } } = 3 4 6 7$ ,2922,2848,1725,1683,1602,1432,1373,1304,1226,1164,1095,1037,1002, $7 5 8 ~ \\mathrm { c m ^ { - 1 } }$ ; UV $\\left( \\mathrm { { M e O H } } \\right)$ ： $_ \\mathrm { m a x } \\left( \\log \\varepsilon \\right) = 2 3 8$ (4.06),289 (0.92)nm; CD $\\left( \\mathrm { { M e O H } } \\right)$ ：d $( \\Delta \\varepsilon ) = 2 1 9$ $( - 4 . 7 6 )$ ,277 (1.77), 333 $\\left( - 1 . 4 4 \\right)$ nm； $\\left( + \\right)$ -HRESIMS: $m / z$ 965.5176 $[ \\mathbf { M \\Sigma } + \\mathbf { \\Sigma } \\mathbf { N } \\mathbf { a } ] ^ { + }$ (calcd for$\\mathrm { C _ { 5 9 } H _ { 7 4 } O _ { 1 0 } N a , }$ 965.5174).",
        "bbox": [
            518,
            495,
            915,
            581
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Sarcglabtene $D$ (4). yellowish gum; $[ \\alpha ] _ { \\mathrm { D } } { } ^ { 2 5 } = - 6 0 . 4$ 0 $c = 0 . 1 0$ inMeOH); $^ { 1 } \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR datasee Table S4; IR $\\nu _ { \\operatorname* { m a x } } = 3 4 7 8$ ,2973,2911,2854,1728,1679,1638,1426,1369,1308,1230,1156,1095,1034,1001, 952, $7 5 6 ~ \\mathrm { c m ^ { - 1 } }$ ; UV $\\scriptstyle ( { \\mathrm { M e O H } } )$ $\\lambda _ { \\mathrm { m a x } }$ $_ \\mathrm { ~ u ~ } ( \\log \\varepsilon ) = 2 3 9$ (4.07),290 (0.93） nm; CD $\\left( \\mathrm { { M e O H } } \\right)$ ： $( \\Delta \\ \\varepsilon ) = 2 1 9$ $( - \\dot { 4 } . 7 7 )$ ,277 (1.76),33 $3 \\left( - 1 . 4 5 \\right) \\mathrm { n m } ;$ $\\left( + \\right)$ -HRESIMS: $m / z 9 6 5 . 5 1 7 7 [ \\mathrm { M } + \\mathrm { N a } ] ^ { + }$ (calcd for$\\mathrm { C _ { 5 9 } H _ { 7 4 } O _ { 1 0 } N a , }$ 965.5174).",
        "bbox": [
            518,
            582,
            915,
            668
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Sarcglabtene E (5). colorless crystal; $\\mathrm { m p } \\ 2 3 7 { - } 2 3 7 . 5 \\ ^ { \\circ } \\mathrm { C } ;$ $\\left[ \\alpha \\right] _ { \\mathrm { D } } { } ^ { 2 5 } =$ $+ 5 8 . 4$ $\\stackrel { \\cdot } { c } = 0 . 1 0$ in MeOH); $^ 1 \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S5; IR:$\\nu _ { \\operatorname* { m a x } } = 3 3 8 8$ ,2957,2876,1852,1772,1730,1660,1558,1452,1384,1113, 963, $8 9 5 ~ \\mathrm { { c m } ^ { - 1 } }$ ； Uv $\\left( \\mathrm { { M e O H } } \\right)$ ： $\\lambda _ { \\operatorname* { m a x } }$ $( \\log \\varepsilon ) = 2 3 2$ (1.53) nm;$\\left( + \\right)$ -HRESIMS: $m / z$ 499.2455 $[ \\mathbf { M } + \\mathbf { N } \\mathbf { a } ] ^ { + }$ (calcd for $\\mathrm { C _ { 3 0 } H _ { 3 6 } O _ { 5 } N a , }$ 499.2455).",
        "bbox": [
            517,
            668,
            915,
            742
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Sarcglabtene $F$ (6). colorless crystal; $\\mathrm { m p ~ 1 8 4 - 1 8 4 . 6 ~ ^ { \\circ } C ; }$ $\\left[ \\alpha \\right] _ { \\mathrm { D } } { } ^ { 2 5 } =$ $+ 5 1 . 1$ 0 $\\stackrel { \\prime } { c } = 0 . 1 0$ in MeOH); $^ 1 \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S6; IR:$\\nu _ { \\mathrm { m a x } } = 2 9 6 2$ ,2918,2849,2821,1777,1645,1413,1153,970,933, 881,$7 5 3 ~ \\mathrm { ~ c m ^ { - 1 } }$ ;UV (MeOH): $\\lambda _ { \\operatorname* { m a x } } \\ \\left( \\log \\ \\varepsilon \\right) \\ = \\ 2 1 7$ （1.42） nm；CD$\\left( \\mathrm { { M e O H } } \\right)$ ： $( \\Delta \\varepsilon ) = 2 1 8$ $( - 3 . 7 7 )$ ，234 $\\left( - 3 . 7 3 \\right) \\mathrm { n m }$ $\\left( + \\right)$ -HRESIMS:$m / z$ 419.2191 $[ \\mathbf { M } + \\mathbf { N a } ] ^ { + }$ (calcd for $\\mathrm { C } _ { 2 5 } \\mathrm { H } _ { 3 2 } \\mathrm { O } _ { 4 } \\mathrm { N a } ,$ 419.2193).",
        "bbox": [
            517,
            743,
            915,
            817
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Sarcglabtene $G$ (7). white amorphous solid; $\\left[ \\alpha \\right] _ { \\mathrm { D } } { } ^ { 2 5 } = + 5 4 . 3$ 0 $\\overset { \\cdot } { c } = \\overset { \\cdot } { }$ 0.10 in MeOH); $^ 1 \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S6; IR: $\\nu _ { \\mathrm { m a x } } =$ 2917,2849,1768,1645,1466,1418,1125,966, 930, $6 4 4 ~ \\mathrm { { c m } ^ { - 1 } }$ ; UV (MeOH): $\\lambda _ { \\mathrm { { m a x } } } \\left( \\log \\varepsilon \\right) = 2 1 8$ (1.08) nm; CD (MeOH): λ ${ \\left( \\Delta \\varepsilon \\right) } = 2 1 6$ $\\left( - 6 . 2 6 \\right)$ ,234 $\\left( - 5 . 8 0 \\right) \\mathrm { n m }$ $\\left( + \\right)$ -HRESIMS: $m / z$ 419.2195 $[ \\mathbf { M } + \\mathbf { N a } ] ^ { + }$ (calcd for $\\mathrm { C } _ { 2 5 } \\mathrm { H } _ { 3 2 } \\mathrm { O } _ { 4 } \\mathrm { N a } ,$ 419.2193). ",
        "bbox": [
            518,
            818,
            915,
            892
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Sarcglabtene $H$ (8). yellowish gum; $\\left[ \\alpha \\right] _ { \\mathrm { D } } { } ^ { 2 5 } = + 5 5 . 3$ 0 $c = 0 . 1 0$ in$\\scriptstyle \\mathrm { M e O H } )$ $^ { 1 } \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S7; IR: $\\nu _ { \\mathrm { m a x } } = 3 4 8 7 , 2 9 4 8$ 1726,1682,1592,1433,1376,1229,1082,1032,993, $8 0 6 ~ \\mathrm { { c m } ^ { - 1 } }$ ; UV(MeOH): $\\lambda _ { \\operatorname* { m a x } } \\left( \\log \\varepsilon \\right) = 2 1 3$ (3.23),255 (3.12),306 (2.34) nm; CD$\\left( \\mathrm { { M e O H } } \\right)$ ： $\\left( \\Delta \\ \\varepsilon \\right) \\ = \\ 2 2 0$ $( - 6 . 2 7 )$ ，272 (4.20)，305 (4.36)，305$\\left( - 2 . 4 7 \\right) \\ \\mathrm { n m } ;$ $\\left( + \\right)$ -HRESIMS: $m / z$ 845.3508 $[ \\boldsymbol { \\mathbf { M } } + \\boldsymbol { \\mathbf { N } } \\boldsymbol { \\mathbf { a } } ] ^ { + }$ (calcd for$\\mathrm { C } _ { 4 8 } \\mathrm { H } _ { 5 4 } \\mathrm { O } _ { 1 2 } \\mathrm { N a } ,$ 845.3507).",
        "bbox": [
            517,
            892,
            915,
            942
        ],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            82,
            71,
            481,
            108
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Sarcglabtene | (9). white solid; $[ \\alpha ] _ { \\mathrm { D } } { } ^ { 2 5 } \\ = \\ - 7 2 . 7$ $\\mathit { \\check { c } } = 0 . 1 0$ in MeOH); $^ 1 \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data see Table S8; IR: $\\nu _ { \\operatorname* { m a x } } = 3 4 6 8$ ,2950, 2840,1729,1659,1598,1432,1377,1300,1217,1112,1092,1037, 1029,991,939,876,762, $6 3 0 ~ \\mathrm { { c m } ^ { - 1 } }$ ; UV (MeOH): $\\lambda _ { \\operatorname* { m a x } } \\left( \\log \\varepsilon \\right) = 2 3 2$ (4.11),287 (2.59) nm; CD $\\left( \\mathrm { { M e O H } } \\right)$ $\\left( \\Delta \\ \\varepsilon \\right) = 2 3 4$ $\\left( + 7 . 2 3 \\right)$ ，276 $\\left( + 2 . 7 4 \\right)$ ，333 $\\left( - 3 . 5 5 \\right)$ nm; $\\left( + \\right)$ -HRESIMS: $m / z$ 573.2458 $[ \\mathbf { M } + \\mathbf { N a } ] ^ { + }$ (calcd for $\\mathrm  C _ { 5 9 } H _ { 7 4 } O _ { 1 0 } N a _  \\it$ 573.2459). ",
        "bbox": [
            84,
            110,
            481,
            196
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Sarcglabtene $G$ (10). white solid; $[ \\alpha ] _ { \\mathrm { D } } { } ^ { 2 5 } \\ = \\ + 7 8 . 1$ 0 $c = 0 . 1 0$ inMeOH); $^ 1 \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S9; IR: $\\nu _ { \\operatorname* { m a x } } = 3 4 6 8$ ,2954,2928,1729,1436,1378,1300,1227,1150,1099,1033,948,765,734$\\mathrm { c m } ^ { - 1 }$ ;UV $\\left( \\mathrm { { M e O H } } \\right)$ ： $\\lambda _ { \\operatorname* { m a x } }$ $( \\log \\varepsilon ) = 2 1 9$ (3.20),287 (1.41) nm; CD$\\left( \\mathrm { { M e O H } } \\right)$ ： $\\left( \\Delta \\ \\varepsilon \\right) \\ = \\ 2 1 1$ $( - 7 . 4 4 )$ ，242 (2.99)， 332 $\\left( - 2 . 5 6 \\right) \\ \\mathrm { n m } ;$ $\\left( + \\right)$ -HRESIMS: $m / z$ 573.2461 $[ \\boldsymbol { \\mathbf { M } } + \\boldsymbol { \\mathbf { N } } \\boldsymbol { \\mathbf { a } } ] ^ { + }$ (calcd for $\\mathrm { C } _ { 3 2 } \\mathrm { H } _ { 3 8 } \\mathrm { O } _ { 8 } \\mathrm { N a }$ 573.2459).",
        "bbox": [
            82,
            196,
            479,
            283
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Sarcglabtene K (11). white solid; $[ \\alpha ] _ { \\mathrm { D } } { } ^ { 2 5 } \\ = \\ + 6 4 . 1$ 0 $c = 0 . 1 0$ in MeOH); $^ 1 \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S9; IR: $\\nu _ { \\operatorname* { m a x } } = 3 4 5 6$ ,2976, 2953,2920,2867,2847,1726,1661,1434,1373,1214,1159,1057, 3481,1012, 882, $7 7 2 ~ \\mathrm { c m } ^ { - 1 }$ ;UV $\\left( \\mathrm { { M e O H } } \\right)$ ： $\\lambda _ { \\operatorname* { m a x } }$ $( \\log \\varepsilon ) = 2 2 6$ (3.55), 298 (1.99) nm; CD (MeOH):λ $\\left( \\Delta \\varepsilon \\right) = 2 1 1$ $\\left( - 1 . 0 8 \\right)$ ,237 (6.65), 33 $\\ge \\left( - 2 . 7 7 \\right) \\mathrm { n m }$ $\\left( + \\right)$ -HRESIMS: $m / z$ 573.2461 $[ \\mathbf { M } + \\mathbf { N a } ] ^ { + }$ (calcd for $\\mathrm { C } _ { 3 2 } \\mathrm { H } _ { 3 8 } \\mathrm { O } _ { 8 } \\mathrm { N a } ,$ 573.2459). ",
        "bbox": [
            82,
            283,
            479,
            371
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Sarcglabtene L (12). white amorphous solid; $\\left[ \\alpha \\right] _ { \\mathrm { D } } { } ^ { 2 5 } = - 6 0 . 3$ $\\overset { \\cdot } { c } = \\overset { \\cdot } { }$ 0.10 in $\\mathbf { M e O H }$ $^ 1 \\mathrm { H }$ and $^ { 1 3 } \\mathrm { C }$ NMR data, see Table S10; IR: $\\nu _ { \\mathrm { m a x } } =$ 3394,2921,2850,1766,1731,1667,1440,1203,1139,923,800,725 $\\mathrm { c m } ^ { - 1 }$ ;UV $\\left( \\mathrm { { M e O H } } \\right)$ ： $\\lambda _ { \\operatorname* { m a x } }$ $_ \\mathrm { a x } \\left( \\log \\varepsilon \\right) = 2 1 1$ (1.32） nm; CD (MeOH): λ $\\left( \\Delta \\varepsilon \\right) = 2 0 4$ (4.81),220 $\\left( - 1 . 9 6 \\right)$ ,243 $( 1 . 2 4 ) \\ \\mathrm { n m }$ $\\left( + \\right)$ -HRESIMS: m/ $z \\ 5 4 3 . 1 9 9 0$ $[ \\mathbf { M } + \\mathbf { N } \\mathbf { a } ] ^ { + }$ (calcd for $\\mathrm { C } _ { 3 0 } \\mathrm { H } _ { 3 2 } \\mathrm { O } _ { 8 } \\mathrm { N a } ,$ 543.1989). ",
        "bbox": [
            82,
            371,
            479,
            445
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "ECD Calculation.The calculations were performed by using the density functional theory (DFT）as carried out in the Gaussian 09. The preliminary conformational distributions search was performed using Yifuyun，and afforded stable conformers for compounds. Further geometrical optimization was performed at the ${ \\mathrm { B } } 3 { \\mathrm { L Y P } } / 6 -$ $3 1 \\mathrm { + G ( d , \\bar { p } ) }$ level.Solvent effect of methanol solution was evaluated at the same DFT level by using the SMD method.TDDFT at B3LYP/ $6 { - } 3 1 1 { + } \\mathrm { G } ( \\mathrm { d } , \\mathsf { p } )$ was employed to calculate the electronic excitation energies and rotational strengths in methanol. ",
        "bbox": [
            84,
            446,
            479,
            557
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "X-ray Crystallographic Data for 5 and 6. Crystal data were obtained ona Bruker APEX-II CCD,Bruker D8 VENTURE dual wavelength $\\mathbf { M o } / \\mathbf { C u } ,$ and Bruker D8 Venture detector using Cu Karadiation $\\left( \\lambda \\ : = \\ : 1 . 5 4 1 7 8 \\ : \\mathring { \\mathrm { A } } \\right)$ ）for5and 6,respectively (Tables S12 and S13).The structures were solved by direct methods (SHELXS97）and refined using full-matrix least-squares difference Fourier techniques.Hydrogen atoms bonded to carbons were placed on the geometrically ideal positions by the“ride on”method.Hydrogen atoms bonded to oxygen were located by the difference Fourier method and were included in the calculation of structure factors with isotropic temperature factors.Crystallographic data for 5 and 6 have been deposited with the Cambridge Crystallographic Data Centre (CCDC: 2435061-2435062). ",
        "bbox": [
            84,
            557,
            479,
            717
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Cell Culture.Human MDA-MB-231，HCT116,AS49,MCF-7, HepG2 cells were cultured in a DMEM medium (Gibco,USA) including $1 0 \\%$ fetal bovine serum (MiniGene，USA）and $1 \\%$ penicillin/streptomycin (P/S）(Beyotime,China） at $3 7 ~ ^ { \\circ } \\mathrm { C }$ with $5 \\%$ $\\mathrm { C O } _ { 2 }$ ",
        "bbox": [
            82,
            718,
            479,
            780
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Cytotoxicity Bioassay.The cells were seeded into 96-well culture plates $( 3 . 0 \\times 1 0 ^ { 3 }$ cells per well),and were treated with different concentrations of each compound for $4 8 \\mathrm { ~ h ~ }$ MTT（ $\\mathrm { ~ \\bar { ~ } { ~ m g / m L } ) }$ was dissolved in PBS and sterile filtered,then $2 0 ~ \\mu \\mathrm { L }$ of the prepared solution was added to each well and cells were incubated for $^ { 4 \\mathrm { h } }$ The formed formazan crystals were dissolved in DMSO ( $\\mathrm { \\langle 1 5 0 ~ } \\mu \\mathrm { L / w e l l \\rangle }$ by constant shaking for $1 0 \\ \\mathrm { m i n }$ at $2 5 ~ ^ { \\circ } \\mathrm { C }$ .The absorbance was measured on a microplate reader (SpectraMax Plus384,Molecular Devices)at a test wavelength of $5 7 0 ~ \\mathrm { n m }$ and a reference wavelength of $6 3 0 ~ \\mathrm { { n m } }$ In each experiment, three replicates of wells were prepared for each sample.The ratio of the living cells was determined by the difference in the absorbance between those of samples and controls.These differences were expressed in percentage,and cytotoxic activity was indicated as an $\\mathrm { I C } _ { 5 0 }$ value.cis-Diammineplatinum dichloride (DDP, CAS:15663-27-1; Sigma, U.S.A) is the positive control. ",
        "bbox": [
            84,
            781,
            479,
            941
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            517,
            72,
            915,
            96
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Flow Cytometric Analysis.MDA-MB-231 cells were seeded into 6-well plates ata density of $1 \\times 1 0 ^ { 6 }$ cells/well and were treated with a series of 4 concentrations (O and $5 ~ \\mu \\mathbf { M } ^ { \\mathrm { ~ } }$ ）for $4 8 \\mathrm { ~ h ~ }$ 、The cells were collected, washed in PBS,and resuspended ina $5 0 0 ~ \\mu \\mathrm { L }$ mixture of S $\\mu \\mathrm { L }$ Annexin V-FITC(Annexin V-PE)and $1 0 \\mu \\mathrm { L }$ propidium iodide（7- AAD；MultiSciences Biotech, Co., Ltd.).BD Accuri C6 and FlowJo V10 software were employed to analyze the cell apoptosis data, respectively.At least l0,ooo events were counted for each sample. ",
        "bbox": [
            517,
            97,
            915,
            196
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Western Blotting.MDA-MB-231 cells were divided into 4 groups: Control, compound 4 $( 1 . 2 5 \\mu \\mathrm { M } )$ , compound 4 $( 2 . 5 \\mu \\mathbf { M } )$ ,and compound 4 $( 5 \\mu \\mathbf { M } )$ . The treatment groups were preincubated with corresponding compounds for $^ \\mathrm { ~ 4 8 ~ h ~ }$ ，Total protein samples were extracted by RIPA buffer containing protease and phosphatase inhibitors. The concentrations of protein were determined by a BCA Kit. Approximately $6 0 \\mu \\ g$ of protein was then separated by $10 \\%$ polyacrylamide gels，and transferred onto PVDF membranes. Following blocked in $5 \\%$ lipid-free milk solution,the membranes were incubated with primary antibodies reactive to Erk,p-Erk,MEK, p-MEK，JNK，p-JNK，p38，p-p38，caspase 3，cleaved-caspase 3, caspase 9，cleaved-caspase 9，PARP，cleaved-PARP，Bax，BCl-2, GAPDH,and subsequently with secondary antibodies.Finally，the membranes were visualized with the ECL kit and analyzed by ImageJ software. ",
        "bbox": [
            518,
            197,
            915,
            381
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Cellular Thermal Shift Assay (CETSA) Analysis.Total cellular proteins of MDA-MB-231 were extracted after $4 8 \\mathrm { ~ h ~ }$ of compound treatment $( 4 \\colon 4 \\mu \\mathbf { M } )$ using RIPA lysis buffer,and the blank group was treated with an equal amount of DMSO as the compound.The lysates were then divided equally into 1O portions and each group was heated with a thermal cycler at different temperatures (42,44,46,48,50, 52, 54,56,58, $6 0 ~ ^ { \\circ } \\mathrm { C } )$ ）for $3 \\ \\mathrm { m i n }$ ，respectively. Then，the tubes were repeatedly frozen and thawed in liquid nitrogen for several times,and the supernatant was centrifuged. The supernatant was centrifuged, and $_ { 4 \\mathbf { X } }$ sampling buffer was added and boiled for $1 0 ~ \\mathrm { \\ m i n }$ before Western blot analysis. ",
        "bbox": [
            517,
            382,
            914,
            518
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "DARTS Assays.Cells were washed with ice-cold PBS and then total protein samples were extracted by RIPA buffer containing protease and phosphatase inhibitors.The protein lysates were mixed with $1 0 \\times$ TNC buffer $\\mathrm { ( 5 0 0 ~ m m o l / L }$ Tris-HCl, $\\mathrm { p H } = 8 . 0 $ $5 0 0 \\ \\mathrm { m m o l / L }$ $\\mathrm { \\Delta N a C l }$ and $1 0 0 \\ \\mathrm { m m o l / L } \\ C a C l _ { 2 } )$ .The lysates in $1 \\times$ TNC buffer were incubated with DMSO or compound 4 for $^ { 1 \\mathrm { ~ h ~ } }$ at room temperature. Following the incubation,each sample was proteolyzed in various concentrations of Pronase (Roche Diagnostics,10165921001） for 10 min at room temperature.After $1 0 \\ \\mathrm { m i n }$ $2 \\mu \\mathrm { L }$ of ice-cold $2 0 \\times$ protease inhibitor cocktail was added to stop proteolysis,and the samples were immediately placed on ice.Digestion was further stopped by adding $5 \\times$ sample loading dye and boiling at $9 5 ~ ^ { \\circ } \\mathrm { C }$ for $1 0 \\ \\mathrm { m i n }$ .An equal portion of each sample was then loaded onto SDS-PAGE gels for Western blotting. ",
        "bbox": [
            518,
            520,
            914,
            692
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Cell Scratch Assays.For the scratch wound assay, $3 \\times 1 0 ^ { 5 }$ cells/ well (three replicates per group）were plated into a 6-well plate and incubated to reach confluence.The monolayer was scratched using a tip and washed with serum-free medium to remove detached cells. Then the cells were cultured in serum-free medium supplemented with 4 $( 1 , 2 , 4 \\mu \\mathrm { M } )$ .HMECs were photographed at $^ { 0 \\mathrm { ~ h ~ } }$ $1 8 \\mathrm { ~ h ~ }$ and/or 36 h postwounding. ",
        "bbox": [
            518,
            693,
            915,
            780
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Molecular Docking.Molecular docking was used to confirm the binding of active components to key targets.We used AutoDock Vina 1.1.2 for semiflexible docking with $78 \\%$ accuracy. The small molecule was the ligand,and Erk 1(PDB:4QTB) and 2(PDB:3ISZ) protein were the receptor. PyMOL 4.3.0 (https://pymol.org/）was used to prepare the structures.AutodockTools (http://mgltools.scripps.edu/ downloads) were used for hydrogenation, charge checking,atom type designation,Gasteiger calculation,and grid box setup.The ligand's root and reversible bond were set in AutodockTools.Structures were converted to “PDBQT”for docking.LibDockScore were calculated, and interactions were analyzed and visualized using Discovery Studio. ",
        "bbox": [
            518,
            781,
            914,
            917
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Statistical Analysis. Statistical analysis was performed with Student's t test by using GraphPad Prism version 8.0.1 (GraphPad ",
        "bbox": [
            518,
            917,
            914,
            942
        ],
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "Software, San Diego, CA). The data have been presented as the mean $\\pm$ standard deviation $\\mathrm { ( { \\bf x } ~ \\pm ~ \\thinspace { \\bf S D } ) }$ ).Generally，all experimentswere carried out with $n \\geq 3$ biological replicates. $P < 0 . 0 5$ was statistically significant. ",
        "bbox": [
            82,
            71,
            479,
            122
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "ASSOCIATED CONTENT ",
        "text_level": 1,
        "bbox": [
            84,
            136,
            286,
            150
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Data Availability Statement ",
        "text_level": 1,
        "bbox": [
            84,
            156,
            275,
            170
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "The NMR data for compounds 1-12 have been deposited in the Natural Products Magnetic Resonance Database (www.npmrd.org). The accession numbers are NP0351330 (Sarcglabtene A)，NP0351331 (Sarcglabtene B)，NP0351332 (Sarcglabtene C)，NP0351333 (Sarcglabtene D)，NP0351334 (Sarcglabtene E),NP0351335 (Sarcglabtene F),NP0351336 (Sarcglabtene G),NP0351337 (Sarcglabtene H),NP0351338 (Sarcglabtene I)，NP0351339 (Sarcglabtene J)，NP0351340 (Sarcglabtene K) and NP0351341 (Sarcglabtene L). ",
        "bbox": [
            84,
            171,
            481,
            295
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "$\\bullet$ Supporting Information ",
        "text_level": 1,
        "bbox": [
            85,
            300,
            273,
            312
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jnatprod.5c00785. ",
        "bbox": [
            84,
            315,
            481,
            341
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "$^ 1 \\mathrm { H }$ NMR and $^ { 1 3 } \\mathrm { C }$ NMR data for 1-12；key 2D correlations of 2-4,10,and 11; streptavidin-treated cell lysates were administered and analyzed,and then stained with Coomassie blue to identify the presence of proteins that may bind to 4; quantifications of MAPK pathwayrelated proteins expression after 4 treatment； quantifcations of EMT-related proteins expression after 4 treatment;quantifications of apoptosis-related proteins expression after 4 treatment; quantifications of DARTSrelated proteins expression after 4 treatment； binding free energy value of 4 to Erk receptor protein determined by Discovery Studio software;original 1D and 2D NMR,HRESIMS,IR, and CD spectra of ${ \\bf 1 } - { \\bf 1 2 }$ and full scans of Western Blot films for data in Figure 8C,8D, 8F,8G,and 8H (PDF) ",
        "bbox": [
            121,
            347,
            479,
            553
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Accession Codes ",
        "text_level": 1,
        "bbox": [
            84,
            565,
            197,
            577
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Deposition Numbers 2435061-2435062 contain the supplementary crystallographic data for this paper.These data can be obtained free of charge via the joint Cambridge Crystallographic Data Centre (CCDC） and Fachinformationszentrum Karlsruhe Access Structures service. ",
        "bbox": [
            82,
            580,
            479,
            647
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "AUTHOR INFORMATION ",
        "text_level": 1,
        "bbox": [
            85,
            663,
            293,
            676
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Corresponding Authors ",
        "text_level": 1,
        "bbox": [
            84,
            683,
            245,
            696
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Lingyi Kong - Basic Medical Research Innovation Center for Anti-Cancer Drugs, MOE and Jiangsu Key Laboratory of Bioactive Natural Product Research, China Pharmaceutical University, Nanjing 211198,China; $\\circledcirc$ orcid.org/0000- 0001-9712-2618; Email: lykong@cpu.edu.cn ",
        "bbox": [
            95,
            697,
            479,
            766
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Jun Luo - Basic Medical Research Innovation Center for AntiCancerDrugs,MOE and Jiangsu Key Laboratory of Bioactive Natural Product Research, China Pharmaceutical University, Nanjing 211198, China; D orcid.org/0000-0002-7892- 011X; Email: luojun@cpu.edu.cn ",
        "bbox": [
            102,
            767,
            481,
            835
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "",
        "text_level": 1,
        "bbox": [
            82,
            846,
            138,
            857
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Danyang Zhang - Basic Medical Research Innovation Center for Anti-Cancer Drugs,MOE and Jiangsu Key Laboratory of Bioactive Natural Product Research, China Pharmaceutical University,Nanjing211198,China Zhiqi Xiao - Basic Medical Research Innovation Center for Anti-Cancer Drugs, MOE and Jiangsu Key Laboratory of ",
        "bbox": [
            97,
            861,
            482,
            942
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Bioactive Natural Product Research, China Pharmaceutical University,Nanjing 211198, China   \nAn Huang -Basic Medical Research Innovation Center for Anti-Cancer Drugs, MOE and Jiangsu Key Laboratory of Bioactive Natural Product Research,China Pharmaceutical University,Nanjing 211198,China   \nPengfei Tang-Basic Medical Research Innovation Center for Anti-Cancer Drugs, MOE and Jiangsu Key Laboratory of Bioactive Natural Product Research,China Pharmaceutical University,Nanjing 211198, China   \nHouli Jiang-Basic Medical Research Innovation Center for Anti-Cancer Drugs, MOE and Jiangsu Key Laboratory of Bioactive Natural Product Research, China Pharmaceutical University,Nanjing211198,China   \nMengmeng Yu- Basic Medical Research Innovation Center for Anti-Cancer Drugs, MOE and Jiangsu Key Laboratory of Bioactive Natural Product Research,China Pharmaceutical University, Nanjing 211198, China   \nZe Zheng - Basic Medical Research Innovation Center for Anti-Cancer Drugs, MOE and Jiangsu Key Laboratory of Bioactive Natural Product Research,China Pharmaceutical University,Nanjing 211198, China ",
        "bbox": [
            533,
            73,
            915,
            375
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Complete contact information is available at: https://pubs.acs.org/10.1021/acs.jnatprod.5c00785 ",
        "bbox": [
            515,
            380,
            846,
            407
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Funding ",
        "text_level": 1,
        "bbox": [
            518,
            422,
            576,
            435
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "This work was financially supported by the Basic Research Project for the Development of Modern Industrial College of Traditional Chinese Medicine and Health at Lishui University. ",
        "bbox": [
            518,
            438,
            915,
            478
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Notes ",
        "text_level": 1,
        "bbox": [
            518,
            483,
            558,
            496
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "The authors declare no competing financial interest. ",
        "bbox": [
            518,
            498,
            855,
            512
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "ACKNOWLEDGMENTS ",
        "text_level": 1,
        "bbox": [
            520,
            528,
            710,
            542
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "This research was supported by the National Natural Science Foundation of China (32070389, 82430118),the Double First Class University Project of China Pharmaceutical University (CPU2022QZ29),the 111 Project from Ministry of Education of China (B18056)，and Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX25_1063). ",
        "bbox": [
            518,
            548,
            915,
            631
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "REFERENCES ",
        "text_level": 1,
        "bbox": [
            520,
            647,
            640,
            661
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "(1）Atanasov,A.G.； Zotchev, S.B.；Dirsch,V.M.；InternationalNatural Product Sciences； Supuran, C. T.； et al. Nat. Rev.Drug.Discovery 2021,20, 200-216.(2)Luo, Z.W.; Yin, F. C.; Wang, X. B.; Kong, L. Y. Chin. J. Nat.Med. 2024,22,195-211.(3)Luo,J.; Zhang,D.Y.; Tang,P.F.; Wang,N.; Zhao, S.; Kong,L.Y.Nat. Prod.Rep.2024,41 (1),25-58.(4) Sun, Y.P.; Chi, J.; Zhang, L.; Wang, S.Y.; Chen, Z.H.; Zhang,H.; Kong, L.Y.; Luo,J.J. Org. Chem. 2022,87,4323-4332.(5) Bai,M.; Liu,Y.-Y.; Li, Y.-L.; Shi,W.-Y.; Li,K.-X.;Lu,L.-W.; LeZhou; Bin Lin; Huang, X.-X.; Song, S.-J.Ind. Crops Prod.2022,183,114983.(6) Wu,X.J.; Cao,D.; Chen,F.L.; Shen,R.S.;Gao,J.; Bai, L.P.;Zhang,W.; Jiang, Z.H.; Zhu, G.Y. ACS. Omega. 2022,7,35063-35068.(7) Wen, J.; Yu,M. M.; Jiang, H.L.; Zhu,Y.; Zhang,D.Y.; Yang, M.Z.; Kong,L.Y.; Luo,J. Bioorga.Chem.2025,158,108327.(8)Cui, Z.R; Wang,Y.Y.; Li,J. X.; Chi,J.; Zhang,P.P.; Kong,L.Y.; Luo,J. Org.Lett. 2022,24,9107-9111.(9) Wang,X.J.; Xin,J. L.; Xiang,H.; Zhao,Z.Y.; He, Y.H.; Wang,H.B.；Mei, G.Y.； Mao,Y.C.; Xiong, J.; Hu,J.F.Chin. Chem. Lett.2024,35,109682.",
        "bbox": [
            515,
            666,
            915,
            941
        ],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "(10) Wu, Z. Y.; Peter, H.R.; Hong, D.Y.Flora of China; SciencePress,1999; p 132.  \n(11) WangY. Y.; Li, Q. R;Chi, J.; Li, J. X.; Kong, L. Y.; Luo,J.Chin.J.Nat.Med.2022,20,215-220.  \n(12）(a) Berova， N.；Ellestad, G.A.；Harada， N. ComprehensiveNatural Products II Chemistry and Biology. 2010，9,91-146.(b) Zhang,D. Y.； Xiao， Z.Q; Wang, N.； Huang,A； Wen,J.;Kong,L.Y.; Luo,J.Bioorga.Chem.2024146,107259.  \n(13) Zhan,Z.C.; Xia, Y.P.; Tang, Q; Zhu,H.H.; Du,J. Y.;Cai,J.X;Chen,Y.J;Wu,Z.N;Li,Y.L;Chen,N.H; WangG.C.;ZangY. B.Phytochem.2023, 215,113859.  \n(14) Wong, K. C.; Tan, M. S.; Ali, D. M. H.; Teoh,S.G.; Osman,H.; Tan, S.K.J. Essent. Oil Res.2009,21,71-73.  \n(15）Flack,H.D.; Bernardinelli, G. Chirality 2008,20,681-690.(16) Sun, Y. P.; Wang, Y. Y.; Li, Y. Y.; Wang, S. Y.; Zhang, D. Y.;Kong,L. Y.; Luo,J.Org.Biomol.Chem.2022,20 (46),9222-9227.(17) Chi,J.; WeiS.S.;Gao,H.L; Xu,D.; Zhang,L; YangL; XuW. J.; Luo,J.; Kong, L. Y. J. Org. Chem. 2019,84 (14),9117-9126.(18) Zhu, W.F.; Guo,S.; Shi,J. L.; Song, K.; Yu,Y.; Tan,R; Lou, S.R; Chen,J.;Qiao,L.P.; Hu, M.Environ. Sci. Technol.Lett 2024,11(10),1068-1074.  \n(19) Lewis,J. B.； Hedrick, G.W.J.Org.Chem.1965,30,42714275.  \n(20)Li J. X;Chi,J; Tang,P.F.; SunY.P.;Lu, W.J; Xu W.J.;Wang,Y.Y.; Luo,J.; Kong, L.Y.Chin.J.Chem.2022,40,603-608.(21) Li, C. J.; Zhang, D. M.; Luo,Y. M.; Yu, S.S.; Li, Y.; Lu, Y.Phytochem. 2008,69, 2867-2874.  \n(22) Liu, X;Fu,J.; Yang J.; Huang,A.C.; LiR F.; Bai,L.P.; Liu,L.; Jiang, Z. H.; Zhu, G. Y.ACS. Omega.2021,6 (8),5898-5909.(23)Li,J. X; Cui, Z. R; Li,Y.Y.; Han, C. H.; Zhang,Y. Q; Tang,P.F.; Cui,L.T.; Zhang,H.; Luo,J.; Kong,L.Y.Chin.Chem.Lett.2022,33,4257-4260.  \n(24) Chi,J.; Xu, W.J.; Wei, S.S.;Wang, X. B.; Li,J. X.; Gao,H.L.;Kong,L. Y.; Luo,J. Org.Let. 2019,21,789-792.  \n(25) Zhou, J. S.; Huang, S.L.; Gao,Y.; Liu,Q. F.; Leng, Y.; Zhou,B.； Yue,J.M.J.Nat.Prod.2022,85,2090-2099.  \n(26) Begley,M.J； Fish,P.V.；Pattenden, G.；Hodgson,S.T.J.Chem. Soc., Perkin Trans.1990,1,2263-2271.  \n(27) Zeng, Y.L.; Liu, J. Y.; Zhang, $\\mathrm { Q . ; }$ Qin, X H.; Li, Z. L.; Sun, G.J; Jin,S.R.Front.Pharmacol.2021,12,652926.  \n(28) Fang,J. Y.; Richardson,B. C.Lancet Oncol.2005,6,322-327.",
        "bbox": [
            82,
            70,
            482,
            590
        ],
        "page_idx": 11
    },
    {
        "type": "image",
        "img_path": "images/9a7ea1fe5ddad5725ee0bc680cf6304d839d3ccebeda1524f627ab61b388d565.jpg",
        "image_caption": [],
        "image_footnote": [],
        "bbox": [
            520,
            542,
            617,
            943
        ],
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "CASBIOFINDERDISCOVERYPLATFORMTM ELIMINATEDATA SILOS. FIND WHAT YOU NEED,W YOU NEED IT. ",
        "text_level": 1,
        "bbox": [
            639,
            623,
            883,
            751
        ],
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "A single platform forrelevant, high-quality biological and toxicologyresearch ",
        "bbox": [
            640,
            753,
            856,
            795
        ],
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "Streamline your R&D ",
        "bbox": [
            654,
            808,
            876,
            828
        ],
        "page_idx": 11
    }
]